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ABSTRACT 
 
Neurons can be divided into various classes according to their location, morphology, 
neurochemical identity and electrical properties. They form complex interconnected networks 
with precise roles for each cell type. GABAergic neurons expressing the calcium-binding 
protein parvalbumin (Pv) are mainly interneurons, which serve a coordinating function. Pv-
cells modulate the activity of principal cells with high temporal precision. Abnormalities of 
Pv-interneuron activity in cortical areas have been linked to neuropsychiatric illnesses such as 
schizophrenia. Hippocampal Pv-neurons are involved in the generation of network 
oscillations, and when their activity level is altered, disruption of oscillatory function ensues. 
Cerebellar Purkinje cells are known to be central to motor learning. They are the sole output 
from the layered cerebellar cortex to deep cerebellar nuclei. Purkinje cells are inhibited by 
Pv-positive interneurons located in the molecular layer and excited by granule cells and 
inferior  olivary  neurons.  There  are  still  many  open  questions  about  the  precise  role  of  Pv-
neurons and Purkinje cells, many of which could be answered if one could achieve rapid, 
reversible cell-type specific modulation of the activity of these neurons and observe the 
subsequent changes at the whole-animal level. 
The aim of these studies was to develop a novel method for the modulation of Pv-neurons 
and Purkinje cells in vivo and to use this method to investigate the significance of inhibition 
in these neuronal types with a variety of behavioral experiments in addition to tissue 
autoradiography, electrophysiology and immunohistochemistry. The GABAA receptor  ?2  
subunit was ablated from Pv-neurons and Purkinje cells in four separate mouse lines. Pv-??2 
mice had wide-ranging behavioral alterations and increased GABA-insensitive binding 
indicative of an altered GABAA receptor composition, particularly in midbrain areas. PC-??2 
mice experienced little or no motor impairment despite the lack of inhibition in Purkinje 
cells. In Pv-??2-partial rescue mice, a reversal of motor and cognitive deficits was observed 
in addition to restoration of the wild-type ?2F77 subunit to the reticular nucleus of thalamus 
and the cerebellar molecular layer. In PC-??2-swap mice, zolpidem sensitivity was restored 
to Purkinje cells and the administration of systemic zolpidem evoked a transient motor 
impairment.  On the  basis  of  these  results,  it  is  concluded  that  this  new method of  cell-type  
specific modulation is a feasible way to modulate the activity of selected neuronal types. The 
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importance of Purkinje cells to motor control supports previous studies, and the crucial 
involvement of Pv-neurons in a range of behavioral modalities is confirmed. 
  
8 
 
LIST OF ORIGINAL PUBLICATIONS 
 
I Leppä E, Vekovischeva OY, Lindén AM, Wulff P, Oberto A, Wisden W, Korpi 
ER. (2005) Agonistic effects of the ?-carboline DMCM revealed in GABA(A) 
receptor ?2 subunit F77I point-mutated mice. Neuropharmacology 48: 469-478. 
 
II Leppä E, Lindén AM, Rabe H, Vekovischeva OY, Wulff P, Lüddens H, Wisden 
W, Korpi ER. (2011) Actions of two GABAA receptor benzodiazepine-site 
ligands that are mediated via non-?2-dependent modulation. European Journal 
of Pharmacology 666: 111-121. 
 
III Wulff P, Goetz T, Leppä E, Lindén AM, Renzi M, Swinny JD, Vekovischeva 
OY, Sieghart W, Somogyi P, Korpi ER, Farrant M, Wisden W. (2007) From 
synapse to behavior: rapid modulation of defined neuronal types with 
engineered GABAA receptors. Nature Neuroscience 10: 923-929. 
 
IV Leppä E, Lindén AM, Vekovischeva OY, Rantanen V, Toppila E, Höger H, 
Sieghart W, Wulff P, Wisden W, Korpi ER (2011) Removal of GABAA 
receptor ?2 subunit from parvalbumin neurons causes wide-ranging behavioral 
alterations. [PLoS ONE, accepted for publication] 
 
  
9 
 
ABBREVIATIONS 
 
5-HT3A 5-hydroxytryptamine (serotonin) receptor type 3A 
AMPA 2-amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl)propanoic acid 
ANOVA analysis of variance  
BAC bacterial artificial chromosome 
CA Cornu ammonis of the hippocampus 
CCK cholecystokinin 
c-Fos a protein encoded by the FOS gene  
CNS central nervous system 
DCN deep cerebellar nuclei 
DMCM methyl 6,7-dimethoxy-4-ethyl-?-carboline-3-carboxylate 
EBOB  ethynylbicycloorthobenzoate 
EC50 concentration producing a half-maximal effect 
EDTA ethylenediaminetetra-acetic acid 
eGFP enhanced green fluorescent protein 
GABA  ?-aminobutyric acid 
GABAA ?-aminobutyric acid receptor type A 
GABAB  ?-aminobutyric acid receptor type B 
GABAC  ?-aminobutyric acid receptor type C 
GAD glutamic acid decarboxylase 
GIS GABA-insensitive 
HEK-293 human embryonic kidney cell line 
Hz Hertz 
L7Cre Purkinje-cell specific promoter 
LTD long-term depression  
IPSC inhibitory postsynaptic current 
mIPSC miniature inhibitory postsynaptic current 
MIST molecules for inactivation of synaptic transmission 
MLI molecular layer interneurons 
mRNA messenger ribonucleic acid 
NMDA N-methyl-D-aspartic acid 
PC Purkinje cell 
PC-?2-swap mouse line with the GABAA receptor ?2F77 subunit returned to Purkinje cells 
PC-??2 mouse line with the GABAA receptor ?2 subunit removed from Purkinje cells 
PPI pre-pulse inhibition 
Pv parvalbumin 
PvCre mouse line with Cre recombinase expressed in parvalbumin-cells 
Pv-??2 mouse line with the GABAA receptor ?2 subunit removed from parvalbumin-cells 
Pv-??2- 
partial rescue  mouse line with the GABAA receptor ?2F77 subunit returned to some parvalbumin-cells 
Ro 15-1788 flumazenil, a benzodiazepine antagonist 
Ro 15-4513 8-azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid 
ethyl ester, a benzodiazepine inverse agonist 
SHIRPA SmithKline Beecham-Harwell-Imperial College-Royal London Hospital-phenotype assessment, 
a mouse behavioral screen 
TBPS t-butylbicyclophosphorothionate 
THIP tetrahydroisoxazolopyridine 
WT wild-type 
?2I77 a mouse line with an I77 point mutation in the ?2 of the GABAA receptor 
 
  
10 
 
1 INTRODUCTION 
The appropriate functioning of the central nervous system is based on the cooperation of 
billions of neurons, which are the smallest units of independent action in the brain and spinal 
cord. There are hundreds, if not thousands, of different types of neurons, all with their special 
niche defined by their location, size, connections to other neurons and the electrical and 
chemical characteristics that allow them to communicate with each other. Networks are 
formed by the creation of neural circuits, in which certain neurons govern the activity of 
others by modulating the amount and timing of excitatory or inhibitory inputs that the 
principal cells receive. Usually these regulating neurons are small, inhibitory interneurons, 
which have connections with up to hundreds of principal neurons, and so are ideally suited 
for the coordination of large neuronal assemblies.  
A class of inhibitory interneurons that use the inhibitory ?-aminobutyric acid (GABA) as 
their primary transmitter, the parvalbumin (Pv)-positive interneurons, have been shown to 
represent a fundamental component of information processing in many brain areas, and thus 
to influence many aspects of central nervous system function, ranging from regulation of the 
level of anxiety to effects on memory and learning. Disruptions in the functioning of Pv-cells 
have been implicated in neurological and neuropsychiatric illnesses such as schizophrenia 
and epilepsy. Although Pv-positive interneurons have been a focus of intensive study in 
recent years, there are nevertheless still many aspects of their roles that need further 
clarification.  
Purkinje cells of the cerebellum have long been known to play an important part in motor 
learning and memory. They are connected through several well-recognized pathways to other 
cell types in the layered cerebellar cortex, and are the sole output from the cerebellar cortex 
to deep cerebellar nuclei. However, there still remain unanswered questions about the role of 
Purkinje cells and the significance of the molecular layer interneurons, which inhibit Purkinje 
cells. Many of these questions could be revealed if it were possible to selectively modulate 
the activity of Purkinje cells and subsequently observe the consequences of modulation at the 
behavioral level. 
An ideal way to pinpoint the significance of a type of neuron is to examine the network and 
determine when specific neurons are active, and when they are not. To this end, various fast, 
reversible ways to modulate the activity of neurons have been developed, with varying 
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success. The method of modulation should cause minimal disturbance to the system at large 
and  to  produce  measurable  changes  at  the  network  level,  so  that  they  can  be  monitored  in  
electrophysiological or behavioral experiments.  
The present studies have been aimed at producing a method by which the selected neuronal 
type, parvalbumin-positive interneurons and cerebellar Purkinje cells are made uniquely 
sensitive to inhibitory modulation with the sedative-hypnotic zolpidem and the convulsant 
methyl 6,7-dimethoxy-4-ethyl-?-carboline-3-carboxylate (DMCM). The behavior and 
sensitivity to zolpidem and DMCM of five lines of transgenic mice have been carefully 
assessed to measure the effect of activation or inactivation of Pv-positive neurons and 
Purkinje cells. By measuring the effect of the genetic alterations at the behavioral level it was 
hoped to attain a comprehensive picture of the significance of these selected cell types to 
diverse behavioral modalities.  
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2 REVIEW OF THE LITERATURE  
 
2.1 Neuronal networks  
 
The central nervous system (CNS) is organized at several structural levels. The gross 
anatomical division of cerebrum and cerebellum divides further into fore-, mid- and 
hindbrain and subsequently into smaller areas like the thalamus, amygdala and basal ganglia. 
These areas in their turn contain discrete nuclei with definite morphological, neurochemical 
and electrophysiological features, which can be characterized by various neuroscientific 
methods to reveal their function in the CNS as a whole. Inside the nuclei and between them 
neurons and glial cells form networks that govern the organized activation of brain areas in 
response to internal and external stimuli. Neurons respond to their environment by chemical 
and electrical processes, which allow them to change their internal state and to relay 
information to other neurons. The mechanisms of ion channel activity and synaptic 
transmission, which are typical of neurons, have been extensively investigated and can be 
influenced in various ways, both experimentally and in clinical settings. The challenges in 
understanding the significance of various brain regions, and ultimately of the different cell 
types, to the brain as a whole lie in identifying the discrete parts of the networks and 
selectively regulating their activity. Much of the earliest work regarding neuronal circuits was 
conducted in the neuronal system of the sea snail Aplysia californica,  which  offers  the  
advantages of very large (up to 1 mm diameter), easily manipulated neurons. In addition their 
numbers are significantly fewer than in the mammalian brain (106 vs.  1012 neurons) 
(reviewed in Kandel and Schwartz, 1982). In such simple systems, the basic principles of 
neuronal activity, such as the molecular mechanisms of learning, can be examined and 
subsequently extrapolated to more complicated vertebrate, mammalian organisms. Kandel’s 
pioneering work provided the first evidence for the role of protein phosphorylation in 
regulating synaptic strength (reviewed in Klein and Kandel, 1978). 
 
Information processing in the brain is a distributed phenomenon not restricted to multiple 
isolated areas, but requiring the cooperation of large assemblies of neurons in spatially 
separate regions (reviewed in Uhlhaas et al., 2008). They are connected through the activity 
of projection neurons originating from one area, with axons reaching across long distances to 
influence the activity in their target region (Lee and Tepper, 2007). Small, nonprojecting 
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interneurons serve important local functions, most often inhibiting the activity of their 
principal cells (reviewed in Rudy et al., 2011). The roles of principal cells and interneurons 
are basically similar in all brain regions, but the circuits they form range from very simple 
two-cell assemblies to intricate interconnected formations with dozens of different neuron 
types all contributing to the control of activity. The most detailed information on the circuit 
level so far has been gained in areas with a definite laminar structure, such as the 
hippocampus (reviewed in Freund and Buzsaki, 1996), the neocortex (reviewed in Freund 
and Katona, 2007) and the cerebellum (Briatore et al., 2010). Knowledge about the exact 
circuitry controlling the activity of different brain regions is essential to understanding CNS 
processes and thus for our ability to influence them in pathological conditions. Many 
neurological and neuropsychiatric illnesses have been shown to afflict distinct neuronal types, 
e.g. dopaminergic cells in Parkinson’s disease and cholinergic neurons in Alzheimer’s 
disease. If one wishes to understand the mechanisms behind these processes, detailed 
information must be obtained on the neurons in question. In many brain areas however, this 
knowledge is incomplete and requires further study. To pinpoint the roles of specific cell 
types, various strategies have been developed. The earliest approaches relied on the removal 
of entire brain structures by surgery (Grusser-Cornehls et al., 1999) or ablation of areas by 
the injection of toxins (Steiner et al., 1997). Such methods, though important in their period, 
are no longer considered specific enough for the goal of clarifying the significance of single 
neurons. Further strategies are needed to reveal the role of neuron classes to the function of 
the whole central nervous system. The opportunity to reversibly modulate the activity of 
selected neuronal types in awake, behaving animals would provide important new insights 
into this phenomenon. 
 
2.1.1 Feedforward and feedback inhibition 
 
The two main types of neuronal inhibition are feedforward and feedback inhibition. Though 
the mechanisms of initiation and synaptic transmitter release are the same in both types, they 
serve different functions in the circuit. In the former type, an inhibitory neuron, usually an 
interneuron, receives excitatory input and releases an inhibitory transmitter, usually GABA. 
The activity of the target neuron, either a principal cell or another interneuron, is reduced for 
as long as transmitter release from the interneuron continues or the target receptor becomes 
desensitized and inactivates (Pouille and Scanziani, 2001). In feedback inhibition, the source 
of interneuron excitation is the principal cell itself. Thus when the principal cell is activated, 
14 
 
it subsequently activates the interneuron, which curtails the activity of the principal cell. This 
type of inhibition serves to limit the duration and the spread of activity among principal cells, 
as well as lateral inhibition between interneurons (reviewed in Bartos et al., 2011). 
Depending on its cytoarchitecture and afferent connections, an inhibitory neuron may provide 
dynamically either feedforward, feedback or both types of inhibition within a network. The 
mapping of neural circuits is facilitated by using simple model organisms like the nematode 
Caenorhabditis elegans, in which all of the 302 cells, including neurons, of the adult 
hermaphrodite animal are known and characterized. The investigation of neural structures is 
further aided by the transparency of this animal, and several complete neuronal circuits have 
been identified. Additionally, by ablating selected neurons with a microlaser beam, the 
functional significance of each of the neurons in the network can be elucidated in turn 
(reviewed in deBono and Maricq, 2005). In larger, more complex organisms, different 
strategies must be utilized to map the neural circuitry underlying behavior, with particular 
emphasis on the challenges in identifying the cell types of interest. 
 
2.2 Interneurons 
 
Interneurons are a ubiquitous and varied class of neurons with several typical characteristics: 
small size, local connectivity and specialized roles in CNS circuitry. The function of 
interneurons is the regulation of the activity of principal cells: depending on the exact 
connectivity, this can mean the modulation of input via the control of dendritic excitability, as 
in the example of inhibitory double-bouquet interneurons (Kawaguchi and Kubota, 1998), or 
the control of axonal output, as in chandelier type interneurons (reviewed in DeFelipe, 1999). 
The actions of interneurons are most often inhibitory, although in some brain areas also 
excitatory interneurons exist (Woodruff et al., 2009). Additionally, during developmental 
stages (reviewed in Wang and Kriegstein, 2009) as well as in disease states like epilepsy 
(Isomura et al., 2003), the actions of the main inhibitory neurotransmitter GABA, utilized by 
the majority of interneurons, may become excitatory in interneurons and principal cells alike.  
Some invertebrate species like nematodes utilize GABA as an excitatory neurotransmitter in 
neuromuscular junctions (Beg and Jorgensen, 2003). However, in the majority of organisms 
GABA is considered as an inhibitory transmitter, and the scope of this review deals mainly 
with its inhibitory properties. 
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In many regions, principal cells, e.g. cortical pyramidal cells outnumber inhibitory 
interneurons by a factor of 10 or more (reviewed in Berghuis et al., 2004), but the 
interneurons nevertheless exert a powerful regulatory influence on network coordination, 
since each interneuron can possess connections to many, in some cases hundreds, of principal 
cells (Fino and Yuste, 2011). As parts of interconnected networks, interneurons may receive 
excitatory or inhibitory innervation locally or from adjacent brain areas and in their turn exert 
either excitatory (Woodruff et al., 2009) or inhibitory influences not only on their principal 
cells, but also other interneurons (reviewed in Klausberger, 2009). Principal cells can also 
reduce the activity of their respective interneurons via retrograde synaptic signaling via the 
release of inhibitory substances like cannabinoids (Wilson and Nicoll, 2001). The many types 
and connections of both interneurons and principal cells can result in massively complex 
networks, the intricacies of which are only slowly being unraveled with intense study 
involving many different disciplines, e.g. in vivo animal models, the identification of 
interneurons via cytochemical markers, electrophysiological characterization of firing 
properties, and even purely computational approaches.  
 
In certain brain areas with relatively simple and well-recognized neuronal circuitry, 
particularly in the hippocampus and to some extent also the cerebral cortex, the establishment 
of classes of interneurons with clearly defined characteristics and modes of action has 
advanced the furthest (reviewed in Rudy et al., 2011). Interneurons can be divided into 
groups according to several criteria, although no one single method of classification has yet 
been proved to hold across all known types of interneurons in all brain areas. The most 
commonly used definitive properties are transmitter identity, localization, connectivity 
pattern, morphology, neurochemistry and electrophysiological character. More information is 
still needed on the different roles of the interneuronal types on network function. The targeted 
regulation of activity of single neuronal types would be one way to gain insights into their 
significance in various brain areas. 
 
2.2.1 Classification of GABAergic interneurons 
 
Most interneurons are inhibitory and their main neurotransmitter is GABA; GABAergic 
interneurons are indeed currently the most thoroughly researched interneuron type. Their 
great diversity has lead to various classification schemes according to brain area and 
chemical as well as electrical properties. The roles of all the identified subclasses of 
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GABAergic interneurons are far from clear. Other transmitters are also utilized by some types 
of interneurons. Cholinergic interneurons of the dorsal and ventral parts of the striatum may 
play a role in the pathophysiology of movement disorders involving the basal ganglia (Pisani 
et al., 2007), glycinergic interneurons of the spinal cord take part in the pattern generator 
arrays of complex movement (Berkowitz et al., 2010) and dopaminergic interneurons of the 
olfactory bulb participate in the processing of olfactory information (reviewed in Cave and 
Baker, 2009). GABAergic interneurons are ubiquitously expressed throughout the CNS, in 
areas ranging from the spinal cord to the olfactory bulb. Several attempts have been made to 
establish definite types of GABAergic interneurons with uniform characteristics; most 
success so far has been achieved in the laminar hippocampal and cortical structures. Cortical 
GABAergic interneurons have been grouped into at least three classes on the basis of the 
expression of cellular marker proteins:  I) somatostatin, II) the serotonin 5-HT3A receptor and 
III) parvalbumin (discussed in the following sections; reviewed in Rudy et al., 2011), 
although other classifications with more main subtypes have also been proposed (reviewed in 
Lewis et al., 2005).  
 
Somatostatin  positive  cells,  typified  by  the  Martinotti  cell,  make  up  ~30  %  of  all  cortical  
interneurons. They are most abundant in cortical layer V, although some are found also in 
layers II-IV. Martinotti cells innervate the distal dendrites of the axonal tuft of the pyramidal 
cells in layer I, with axonal collaterals also synapsing with apical and basal pyramidal 
dendrites (Uematsu et al., 2008). Their firing pattern is low threshold spiking, and the 
excitatory input they receive is facilitating, which makes them prime candidates for feedback 
inhibition. Further subdivisions of somatostatin positive interneurons can be constructed on 
the basis of their calbindin immunoreactivity.  
 
5-HT3A receptor-positive cells form the second group of cortical inteneurons, also with ~30% 
prevalence. This cell population is rather heterogeneous and includes vasoactive intestinal 
peptide positive cells with morphologies varying from bitufted and bipolar to multipolar 
structures, displaying a diverse variety of cytochemical markers and electrophysiological 
properties (Lee et al., 2010). In addition to serotonin, 5-HT3A receptor-positive interneurons 
can be excited by asetylcholine acting on nicotinic receptors, irrespective of their cortical 
layer, morphology or firing profile. Based on their location in the superficial cortical layers II 
and III, 5-HT3A positive neurons have been postulated to provide feedforward or feedback 
inhibition in relation to long-range cortico-cortical inputs (Petreanu et al., 2009). 
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Neurogliaform cells are relatively well-known 5-HT3A positive cells with small, round somas 
and radially extending dendrites. They are unusual in that they share electrical synapses with 
other types of interneurons in addition to each other; usually electrically connected 
interneurons only relate to neurons of the same type (Olah et al., 2007). This is proposed as a 
way to connect multiple parallel interneuron networks and so to promote network 
synchronization. Another interesting feature of neurogliaform cells is the localization of 
synaptic vesicles to sites not adjacent to postsynaptic junctions, which may be evidence that 
they participate in tonic extrasynaptic transmission (Olah et al., 2009).  
 
Additional types of cortical GABAergic interneurons are calbindin- or calretinin-positive 
double bouquet cells, which innervate distal dendrites of pyramidal cells (Kawaguchi and 
Kubota, 1998), and calretinin-positive Cajal-Retzius cells, which form synapses in the axonal 
tuft of the pyramidal cell (Kirmse et al., 2007). In the hippocampal CA1 area alone, 12 
different types of GABAergic interneurons have recently been identified (reviewed in 
Klausberger, 2009), which testifies to the multiform character of this class of cell. 
 
2.2.2 Parvalbumin-positive interneurons 
 
Parvalbumin (Pv)-positive interneurons in cortical and hippocampal areas synapse on the 
soma  or  proximal  dendrites  of  the  pyramidal  cell,  or  in  some  cases  on  the  axon  initial  
segment (Gonzalez-Burgos 2005). They have a typical fast-spiking firing pattern: they fire 
sustained, high-frequency trains of brief action potentials and have little spike frequency 
adaptation. These neurons have very low input resistance and fast membrane time constants, 
which make them ideal for developing fast synaptic responses (Gonzalez-Burgos et al., 
2005). Fast spiking cortical interneurons exert a powerful and temporally precise influence on 
their target cells. They are under strong excitatory control from the thalamocortical inputs of 
layer IV and intracortical inputs of all six layers, all of which creates a narrow time window 
of feedforward inhibition to achieve temporal summation of the excitatory input and spike 
generation of principal cells (Goldberg et al., 2008). Fast-spiking interneurons typically 
contain many glutamatergic AMPA receptors and consequently are able to follow high-
frequency repetitive stimulation with high fidelity, which enables them to mediate the rapid 
changes conveyed by their numerous glutamatergic inputs (Cruikshank et al., 2007). 
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Figure 1. Interneuron types in the cerebral cortex. P pyramidal cell. DB double bouquet cell, Ch 
chandelier cell, Ng neurogliaform cell, M Martinotti cell, B basket cell, CRC Cajal-Retzius cell, ais 
axon initial segment, G other GABAergic neurons.  + parvalbumin-positive cell. (Modified from Lewis 
et al., 2005). 
 
The  two  most  important  types  of  cortical  GABAergic  Pv-interneurons  are  basket  cells  and  
chandelier  cells.  Basket  cells  reside  in  layer  III,  close  to  the  pyramidal  cells,  synapsing  on  
their soma and proximal dendrites. The axons of several basket cells converging on the 
perisomatic area of the pyramidal cell form a basket-like structure. They are likely to be the 
prevalent inhibitory influence in the neocortex (reviewed in Freund and Katona, 2007). 
Basket cells have been shown to innervate also other basket cells, in addition to pyramidal 
cells, while chandelier cells only synapse with pyramidal cells (Tamas et al., 1998). Two 
types of basket cells are recognized, the Pv-positive and the cholecystokinin (CCK)-positive. 
The latter have slower kinetics of activation and inactivation suited to the integration of 
excitatory signals (Glickfeld and Scanziani, 2006) and are thought to participate in the fine-
tuning of network activity and perhaps the processing of information concerning mood, 
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emotional and motivational types of physiological status. One of the most essential tasks of 
the Pv-positive basket cells is the generation and control of network oscillations (Galarreta 
and Hestrin, 2001). CCK-positive cells can be retrogradely inhibited by the pyramidal cells 
via cannabinoid signaling (so-called depolarization-induced suppression of inhibition), but 
Pv-positive cells cannot (Wilson and Nicoll, 2001). This difference in the ability of the 
pyramidal cells to curtail one form of inhibition but not the other is intriguing and is likely to 
be connected to the different roles of the two types of basket cells. Pv-positive basket cells 
have a rather rigid mode of action that cannot be modulated as easily and in as many ways as 
the CCK-positive cells, as befits a system that has a clockwork-like oscillatory function. On 
the other hand, hippocampal Pv-positive basket cells are presynaptically modulated by ? 
opioid (Drake and Milner, 2002) and M2 muscarinic (Hajos et al., 1998) receptors; the 
activation of these receptors results in reduction of the firing of basket cells. M2 antagonists 
increase gamma oscillations via disinhibition of basket cells (Palhalmi et al., 2004). 
Experiments with selective activation or inhibition of basket cells would give further 
information on the role of these specialized neurons in the regulation of oscillatory functions 
in information processing. 
 
Hippocampal Pv-interneurons are distinct from other interneurons in that region in that they 
receive much less GABAergic afferent input; only 6 % of their synaptic input is inhibitory 
(Gulyas et al., 1999). In contrast, they receive an extensive excitatory input via ~15000 
synaptic connections from all layers of the hippocampus: feedforward excitation from 
Schaffer collaterals and entorhinal fibers, thalamic afferents from the nucleus Reuniens in 
addition to feedback excitation from CA1 recurrent collaterals (reviewed in McBain and 
Fisahn, 2001).  
 
In addition to conventional chemical synapses, both hippocampal and cortical basket cells are 
connected to each other via gap junctions, transcellular channels located in their dendrites. 
Gap junctions are formed by specialized proteins called connexins, and they allow direct 
bidirectional electrical contact and exchange of signals between neurons. They are an 
extremely rapid, powerful method for achieving synchronization of a group of cells (Fukuda, 
2009). Gap junctions permit the formation of interconnected assemblies well suited to the 
control of large pyramidal cell populations to gamma frequency oscillations. It has been 
shown that gap junctional connections amplify the magnitude of gamma oscillations, though 
they do not appear to affect their generation (reviewed in Nakazawa et al., 2011). Like most 
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interneurons expressing gap junctions, except for the neurogliaform cells, Pv-positive basket 
cells only form gap junctions with cells of the same neuronal subtype (Blatow et al., 2003). It 
has been estimated that each Pv-positive basket cell is connected to 20-50 other basket cells, 
either synaptically or via gap junctions (Amitai et al., 2002). 
 
 The  role  of  Pv-positive  chandelier  cells  differs  from  that  of  basket  cells  and  seems  to  be  
somewhat controversial. Chandelier cells are located in laminar structures like the neocortex 
and hippocampus, but are missing from the cerebellar layers, in addition to being found in the 
amygdala, which does not consist of layers (reviewed in Howard et al., 2005). They are most 
abundant in cortical layers II/III, but much fewer in number that Pv-positive basket cells 
(Inda et al., 2007). They have a characteristic branched structure and they form synapses 
specifically on the axon initial segment of the pyramidal cell, with vertical axonal varicosities 
called cartridges focused on the axon initial segment in a linear manner. A single axonal 
cartridge innervates a single axon initial segment; one axon initial segment may harbor as 
many as five synapses with chandelier cell cartridges from a single or several chandelier cells 
(reviewed DeFelipe, 1999). Chandelier cells do not innervate other interneurons, and do not 
receive inputs on their own axon initial segments. They are target-specific according to their 
localization: visual cortex chandelier cells prefer cortico-cortical pyramidal cells, while in the 
entorhinal cortex layer II/III, they prefer pyramidal cells that project to the hippocampus 
(Arellano et al., 2002). The innervation targeting chandelier cells is less clear, but is likely to 
show similar specificity. In layers II/III of mouse somatosensory cortex, chandelier cells 
receive an excitatory input within the same layer in addition to layer Va, whereas the 
inhibitory input originates from layers I and II/III. As logically follows from the synaptic 
localization on the axon initial segment, chandelier cells have a powerful influence on the 
initiation of the action potential. Surprisingly, despite being GABAergic, they have been 
postulated to have an excitatory effect on the pyramidal cells, facilitating the generation of an 
action potential. Three points have been raised to support this proposal: glutamatergic 
disynaptic EPSPs can be recorded after a single spike in a chandelier cell, the GABA reversal 
potential  in  the  chandelier  cell-pyramidal  cell  synapse  is  above  the  resting  potential  of  the  
neuron, and the KCC2 potassium-chloride cotransporter is missing from the axon initial 
segment of the pyramidal cell, which could lead to less chloride extrusion and account for the 
observed elevated GABA reversal potential (reviewed in Woodruff et al., 2010). The 
possibility of excitation would not preclude an inhibitory function of the chandelier cell, the 
mode of action being dependent on the membrane potential of the postsynaptic cell, and 
21 
 
consequently the state of excitation of the whole network would govern the mode of action of 
the chandelier cell. The lack of specific markers to separate chandelier cells from Pv-positive 
basket cells has been an obstacle in investigating their function. 
 
In  addition  to  basket  and  chandelier  cells,  another  type  of  Pv-interneuron  called  the  
multipolar bursting cell, has been localized to the border between layers I and II, with 
synapses at the distal dendrites of the pyramidal cell. Its firing properties differ from the two 
better known interneuron types in that after initially firing a few bursts, it pauses and follows 
with a train of low-frequency tonic spikes, and is able to undergo paired-pulse facilitation, 
unlike basket and chandelier cells. The prevalence and functional significance of the 
multipolar bursting cell are not known at present (Blatow et al., 2003). 
 
The hippocampus contains additional types of GABAergic Pv-positive inhibitory 
interneurons. Unlike the soma-focused basket cells, oriens-lacunosum moleculare cells 
synapse  on  the  distal  dendrites,  whereas  bistratified  cells  focus  their  synapses  on  both  the  
basal and apical dendrites of the pyramidal cell (reviewed in McBain and Fisahn, 2001). 
These cell types are likely to have functions very different from the basket or chandelier cells. 
A mouse line with a genetic ablation of the glutamatergic AMPA receptor GluR-A subunit in 
Pv-cells was found to have impaired spatial working memory and disrupted exploratory 
behavior in addition to displaying alterations in hippocampal oscillations (Fuchs et al., 2007). 
In  a  mouse  line  with  genetic  removal  of  the  glutamatergic  NMDA  receptor  from  Pv-cells,  
electrophysiological recordings from the hippocampal CA1 area revealed a disruption in the 
oscillations, with altered theta frequency and increased gamma frequency activity as well as 
deficits in certain forms of memory and learning, but no changes in open field exploratory 
behavior (Korotkova et al., 2010). In a later report with the same mouse line, a decreased 
habituation of the startle reflex, a simplistic form of learning, was observed, although the 
startle reflex itself, as well as the pre-pulse inhibition of startle, was normal. Further 
disruptions in associative fear learning and an overloading of working memory were 
reported, although spatial reference memory in the Morris Water Maze paradigm was normal 
(Carlen  et  al.,  2011).  These  studies  underline  the  importance  of  the  excitation  of  Pv-
interneurons in hippocampal-dependent phenomena at both the electrophysiological level 
(oscillations) as well as their resulting whole animal-counterparts, i.e. behavioral experiments 
conducted in awake, moving animals. These examples of disrupted function of Pv-cells due 
to decreased excitation would benefit if it were possible to undertake a reversal of the setting: 
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i.e. investigate the effects of decreased inhibition of Pv-cells. A model with impaired 
inhibition in Pv-cells would offer an important opportunity to observe the activity of the 
network in the presence of increased inhibition toward the principal cells. 
 
Though the neocortex and hippocampus are the most thoroughly researched areas with regard 
to Pv-interneuron function, many other areas also harbor GABAergic Pv-positive 
interneurons. The basolateral division of the amygdala contains Pv-cells with a fast-spiking 
firing pattern and synapse localization in the soma and proximal dendrites of the principal 
cells,  as  well  as  an  axo-axonic  cell  reminiscent  of  the  cortical  chandelier  cell,  in  that  its  
influence  can  be  excitatory  (reviewed  in  Spampanato  et  al.,  2011).  The  Pv-cells  of  the  
basolateral amygdala show increased expression of the immediate early gene c-Fos, a marker 
of neuronal activity, after the systemic administration of anxiogenic compounds, such as 
benzodiazepine inverse agonists (Hale et al., 2010), highlighting the importance of Pv-cells in 
the amygdala in the regulation of anxiety-related behaviors. The basolateral amygdala is a 
well-known substrate of anxiety in both animal models of anxiety and in human anxiety 
disorders. In the spinal cord, Pv-interneurons are present in several regions including the 
ventral horn. They may be used as an early marker of the large-diameter 1a fibers that 
synapse with motoneurons. Some Pv-cells of the spinal cord may be involved in polysynaptic 
pathways to motoneurons, while some may be Renshaw cells, which provide recurrent 
inhibition  to  motoneurons  (Dekkers  et  al.,  2002).  In  the  striatum,  only  3-5%  of  cells  are  
GABAergic Pv-interneurons, but they nevertheless exert a powerful inhibitory influence on 
the activity of the projection neurons. A single Pv-interneuron makes contact with many 
projection neurons and thus may have a coordinating function. Striatal Pv-interneurons 
appear to play a role in the motor symptoms observed in an animal model of idiopathic 
dystonia (Gernert et al., 2000).  
 
There are several Pv-positive interneuron types in the molecular layer of the cerebellum 
(Mittmann  et  al.,  2005).  The  function  of  these  basket  and  stellate  cells,  like  that  of  Pv-
interneurons in other brain areas, is to impose a precise temporal control over the output of 
their principal cells, the Purkinje cells. Parallel fibres originating from granule cells activate 
the molecular layer interneurons, which rapidly modulate the activity of Purkinje cells in a 
feed-forward manner (Mittmann et al., 2005). Molecular layer interneurons are highly 
interconnected and form a network capable of mediating very fast responses to regulate the 
intrinsically active Purkinje cells (Kondo and Marty, 1998). Pv-positive fast-spiking 
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interneurons form a part of an inhibitory feedforward circuit also in the red nucleus (Liu et 
al., 2002). The fairly uniform characteristics of Pv-positive interneurons across different brain 
areas emphasize that this cell type is an important component of inhibitory control and 
network coordination. However, many of the details of Pv-cell function still await 
clarification. Ways to specifically modulate their activity in vivo in behaving animals would 
be of great value in understanding their functional roles in the regulation of activity in 
different brain areas.  
 
2.2.3 Coordinating function and Pv-interneurons: network oscillations 
 
Oscillations are rhythmic fluctuations in the extracellular field potential of neurons, which 
have been observed in a variety of brain areas, including the olfactory bulb, thalamus, 
hippocampus and cortex. They are thought to be crucial to the maintenance of the temporal 
precision of pyramidal cell firing, and require the recruitment of interneuron and pyramidal 
cell populations into neuronal assemblies, which encode sensory and other kinds of data into 
temporally sequential representations. The functions of the various types of oscillations have 
not been fully established, but they are believed to support the transfer and processing of 
information  within  and  between  brain  regions  (Hartwich  et  al.,  2009),  and  to  assemble  the  
features detected in different cortical areas to a unified perceived object (Whittington et al., 
1995). Oscillations are divided according to frequency into several classes, the most 
important being theta (4-12 Hz), gamma (30-80 Hz) and fast ripple oscillations (120-200 Hz) 
(reviewed in Benes and Berretta, 2001). When the appropriate type of interneurons are 
excited, they generate rhythmic, synchronized activity within the interneuron network and 
inhibit pyramidal cells in a coordinated manner. The pyramidal cells can be excited only in 
the  phase  of  the  oscillation  cycle  when  inhibition  is  at  its  lowest.  Thus  pyramidal  cell  
activation is a self-terminating circuit: activated pyramidal cells excite interneurons, which, 
after a monosynaptic delay inhibit the pyramidal cells in a feedback loop. Pyramidal cells are 
the main source of excitation for the interneurons, and when pyramidal cells are inhibited, the 
activity of the interneurons becomes reduced, thus permitting the next firing phase of the 
pyramidals (reviewed in Fries et al., 2007).  
 
There are several reasons why Pv-positive basket cells are thought to be responsible for the 
generation of gamma oscillations: they are relatively numerous, e.g. in the hippocampus 
accounting for ~20 % of all GABAergic interneurons; they are abundantly interconnected to 
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other basket cells via synapses and gap junctions (Gulyas et al., 1999); one basket cell can 
innervate large numbers of pyramidal cells; they have fast, non-adapting kinetics and a high 
intrinsic resonance frequency ideal for the generation of gamma oscillations (Pike et al., 
2000), and finally, their localization at the perisomatic region of the pyramidal cell represents 
a prime position for the distribution of the gamma oscillations generated in the basket cell 
network to the pyramidal cells. Pv-positive basket cells are also very active during gamma 
oscillations; they fire at a rate of ~1 per gamma cycle, precisely phase-locked to the 
oscillations (Mann et al., 2005). Gamma oscillations occur during all behavioral states. They 
superimpose upon, and are modulated by slower theta activity, and are believed to offer a 
temporal framework for binding and processing of information (Csicsvari et al., 2003).  
 
Theta oscillations are thought to be the “online state” of the hippocampal network, and they 
occur during spatial navigation, learning, memory formation and retrieval, as well as in REM 
sleep (reviewed in Klausberger, 2009). It has been shown that spatial information can be 
encoded into the firing of a hippocampal place neuron in such a way that the cell undergoes 
phase precession during the movement of the animal in the so-called place field of the 
neuron, a defined visual area to which the neuron responds. During the ~1 s duration of 
movement across the place field, 7-12 theta cycles are produced, and the principal cell fires at 
an earlier and earlier phase of the cycle toward the end of the movement. The more powerful 
the excitation of the pyramidal cell, the earlier in the cycle it fires (Senior et al., 2008). 
Interneurons contribute to the theta rhythm as well as the gamma rhythm. The output of 
chandelier cells is markedly increased during high network activity, and they may be 
recruited to curtail excess excitation. Animals in which theta oscillations have been ablated, 
have impaired performance in tasks measuring spatial and nonspatial working memory 
(reviewed in Uhlhaas et al., 2008), evidence of the fundamental role of theta oscillations in 
this type of memory. 
 
Ripple oscillations occur during resting, slow-wave sleep and consummatory behavior as well 
as the replay and consolidation of memories (Racz et al., 2009). The contribution of Pv-
positive interneurons to ripple oscillations has been demonstrated in transgenic mice in which 
the excitatory drive from pyramidal cells to the interneurons has been reduced (Racz et al., 
2009). Other types of oscillations remained unchanged in these mice, but ripple oscillations 
were facilitated, implying that the excitation from pyramidal cells to Pv-interneurons is a key 
regulating factor in reducing ripple activity.  
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2.2.4 Other parvalbumin-positive neuronal types 
 
Although GABAergic Pv-positive interneurons in various brain areas are probably the most 
thoroughly  researched  cell  type  expressing  the  parvalbumin  protein,  other  GABAergic  Pv-
positive cell populations have also been identified. Projections from the globus pallidus to the 
striatum consist mainly of GABAergic inhibitory neurons, of which 5-19% are Pv-positive, 
depending on the pallidal subregion (Kita and Kita, 2001). These pallidar projection neurons 
regulate the activity of striatal projection neurons by innervating striatal GABAergic 
interneurons. In the substantia nigra pars reticulata, GABAergic Pv-positive cells inhibit 
dopaminergic neurons via local axon collaterals, in addition to projecting long distances to 
other sites, e.g. thalamus and the striatum. They may be the main source of intranigral 
inhibition. Consequently, afferent inhibition of these intranigral GABAergic neurons results 
in disinhibition of the dopamine cells (Lee and Tepper, 2007). A population of GABAergic 
Pv-positive neurons projects from the medial septum-diagonal band of Broca region to the 
hippocampus, where it participates in the generation of theta oscillatory rhythm (Simon et al., 
2006). Discrete nuclei within the auditory brainstem also contain Pv-positive neurons, some 
of which project between the nuclei and some to more distant regions (Fredrich et al., 2009).  
Cerebellar Purkinje cells are another important Pv-positive cell type (Schmidt et al., 2007) 
with a widely recognized role in the control of movement and motor learning.  
 
It is important to note that also neurons harboring transmitters other than GABA contain 
parvalbumin. These neurons may still express GABAA receptors and thus be modulated by 
GABAergic  afferents  or  local  inhibition,  which  considerably  extends  the  variety  of  Pv-
positive neurons affected by GABAergic transmission. Pv-positive pyramidal cells projecting 
from the retrosplenial and somatosensory cortices to caudal parts of the striatum are for the 
most part glutamatergic, with the exception of a small GABAergic subpopulation (Jinno and 
Kosaka, 2004). Thalamocortical projections originating from the anteroventral nucleus of 
thalamus are positive for parvalbumin, but negative for the GABA-synthesizing enzyme 
glutamic acid decarboxylase (GAD) (Danos et al., 1998). The hypothalamic mammillary 
bodies also contain Pv-positive, GAD-negative, glutamate/aspartate neurons projecting to the 
anterior thalamus and the midbrain (Bernstein et al., 2007). In the rodent entorhinal cortex, a 
small number of pyramidal projection neurons are Pv-positive (Wouterlood et al., 1995), as is 
also the case in the rodent auditory cortex (de Venecia et al., 1998). 
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2.2.5 Significance of Pv-positive neurons in pathophysiology 
 
Given their ubiquitous influence on the precision of principal cell firing and the contribution 
to overall network coordination, it is not surprising that deficits in the functioning of Pv-
positive interneurons have far-ranging consequences on information processing in many brain 
areas. Schizophrenia is one of the illnesses where GABAergic functioning is abnormal and 
where Pv-positive interneurons play a significant role (reviewed in Daskalakis et al., 2007). 
An overall reduction in cortical inhibitory tone and synchronized activity has been detected in 
the brains of schizophrenic patients (reviewed in Benes and Berretta, 2001). The number of 
Pv-immunoreactive interneurons is decreased in the prefrontal cortex (Beasley and Reynolds, 
1997) as well as in all hippocampal subfields (Zhang and Reynolds, 2002) of schizophrenic 
patients. These studies have not clarified whether the Pv-positive neurons are simply 
destroyed, whether they have not developed appropriately in the first place, or whether the 
production of GABA or the expression of parvalbumin has been disrupted, although in the 
study of (Hashimoto et al., 2003) it was proposed that in most cases the last possibility may 
occur. A decrease in the number of axonal cartridges formed by chandelier cells on the axon 
initial segments of pyramidal cells was observed in the prefrontal cortex of schizophrenic 
patients, pointing to alterations in the output control of these pyramidal cells (Woo et al., 
1998). Since the expression of the Ca2+-buffering parvalbumin protein begins relatively late 
in postnatal life, in addition to Pv-positive cells displaying a fast-firing phenotype and 
expressing many glutamatergic NMDA receptors, it has been speculated that these neurons 
are especially vulnerable to excitotoxic injury during development (reviewed in Jones, 2010). 
In addition to cell death, excitotoxicity can also cause synaptic and dendritic atrophy 
(reviewed in Woo et al., 2010). Cortical networks are still undergoing plastic preprogrammed 
changes as late as during adolescence, with oscillatory activity which is governed by Pv-
positive interneurons playing a role in the maturation process (reviewed in Uhlhaas and 
Singer, 2010). Schizophrenia usually appears in adolescence or early adulthood, and it is 
conceivable that early damage to Pv-interneurons may ultimately manifest as a lack of 
appropriate coordinative function during this reorganization period, leading to clinical illness.  
 
In schizophrenia as in many other neuropsychiatric disorders, Pv-positive interneurons are the 
only class of interneurons affected, other types of interneurons apparently being protected by 
their different chemical and electrophysiological properties. One of the hallmarks of 
schizophrenia which encompasses several aspects of cognitive abnormalities, such as 
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attentional deficits and sensory disintegration, is impairment of working memory. Working 
memory involves the prefrontal cortex, requires coordination between multiple brain regions 
and has been found to be associated with memory-related theta (Schmiedt et al., 2005) and 
gamma (Fries et al., 2001) oscillatory activity. EEG recordings taken during working 
memory tasks provide evidence for the involvement of gamma oscillations in the 
maintenance of information in working memory, and possibly even for a role in long-term 
memory, as there appears to be a relationship between the amount of gamma activity during 
memory acquisition and the efficiency of the recall phase (reviewed in Uhlhaas et al., 2008). 
Indeed gamma frequency and also other types of oscillations were reduced in EEG recordings 
taken from schizophrenic patients during working memory tasks (reviewed in Jones, 2010). 
Reductions in gamma oscillations have also been observed in various animal models of 
schizophrenia, where deficits in sensorimotor gating are the prevalent cognitive symptom, in 
conjunction with a decrease in Pv-positive interneurons in the entorhinal cortex (Cunningham 
et al., 2006). The disruption of rhythmic oscillatory activity throughout various brain areas 
would be a logical mechanism to account for the typical symptomatology of schizophrenia: a 
disconnection of cognitive, emotive and affective processes. The fact that the function of one 
of the key players of oscillation, the Pv-positive interneurons, is impaired by a decrease in the 
parvalbumin content and the altered connectivity to principal neurons in the areas thought to 
be most crucial to cognition, the cortex and the hippocampus (as discussed in the previous 
section), adds weight to the link between disrupted oscillations and schizophrenia. An 
interesting approach to the dissection of the significance of Pv-cells to oscillations would be 
to isolate their function by either specifically decreasing or increasing their activity and 
observing the possible alterations in different oscillatory frequencies. 
 
 Epilepsy is another category of neurological illness that crucially depends on the balance of 
inhibition and excitation of the CNS. The various types of epilepsy all have one feature in 
common, i.e. there are episodes of uncoordinated paroxysmal electrical activity, which are 
generated either in specific epileptic foci or more generally throughout the brain. Various 
experimental models of focal epilepsy have led to the hypothesis that neocortical basket and 
chandelier  cells  along  with  their  axon  terminals  are  destroyed  in  epilepsy,  resulting  in  
deficient inhibitory control of pyramidal cells (reviewed in DeFelipe, 1999). Pv-positive 
interneurons in the hippocampal dentate gyrus are selectively damaged in patients with 
temporal lobe epilepsy as well as in an animal model of temporal lobe epilepsy (Zhou et al., 
2009; Gill et al., 2010). The excitatory drive to cortical interneurons is decreased in a model 
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of epileptic cortical dysplasia, suggesting that deficient inhibition may lead to overexcitation 
of  pyramidal  cells  and  thus  to  seizure  activity  (Zhou  et  al.,  2009).  Pyramidal  cells  are  the  
most important source of cortical efferent axons and intracortical collaterals, and as such, are 
fundamental in the spreading of epileptiform activity (Ribak, 1985). In the hippocampal 
dentate gyrus, many granule cells, which have a principal cell function similar to cortical 
pyramidal cells, are destroyed in epilepsy, and the few survivors are densely innervated by 
both perisomatic basket formations and an increased number of chandelier cell axonal 
cartridges (Arellano et al., 2004), perhaps due to axonal sprouting. It has been proposed that 
understanding how chandelier cells govern the axonal output of pyramidal cells is essential if 
one wishes to explain the appearance of epileptic discharges in hippocampal and cortical 
tissue. Some controversy exists as to the epilepsy-induced changes in chandelier cell 
function: in some studies a loss of chandelier cell synapses on the axon initial segment has 
been observed, but in others the numbers of axonal cartridges have even increased (Wittner et 
al., 2005). Increased synaptic contact between chandelier cells and principal cells could lead 
to pathological hypersynchrony in the firing of principal cells. Intriguingly, in temporal lobe 
epilepsy, where there are sclerotic changes in the hippocampus, the function of Pv-
interneurons has in some cases been found to be excitatory (Cohen et al., 2002), perhaps due 
to denervation-induced alterations in chloride ion transporters and membrane reversal 
potentials. 
 
Schizophrenia and epilepsy are the most thoroughly researched diseases with respect to Pv-
positive cells. Other neurological disorders where Pv-positive cells, both interneurons and 
projection neurons have been implicated, are Parkinson’s disease and multiple sclerosis. In 
Parkinson’s disease, the function of pallidar inhibitory Pv-positive neurons projecting to the 
subthalamic nucleus is disrupted, leading to disinhibition of the subthalamic nucleus 
dopaminergic neurons and finally excessive inhibition of the neocortex and brainstem motor 
nuclei (reviewed in Berghuis et al., 2004). In an animal model of multiple sclerosis, Pv-
positive interneurons within the striatum have been specifically destroyed by a yet unknown 
mechanism, and in multiple sclerosis patients, the function of cortical Pv-interneurons has 
been found to be compromised (Rossi et al., 2010). The involvement of Pv-interneurons in 
the altered oscillatory activity and cognitive deficits in autism has also been proposed 
(Gogolla et al., 2010). 
 
 
29 
 
2.3 Cerebellar circuits and Purkinje cells 
 
The cerebellum is a relatively well-characterized structure with regard to its layered neuronal 
architecture and the connections its various cell types make with each other. Its main domain 
of influence has traditionally been thought to be the control of movement and motor learning, 
including gait, posture and balance, but more recent research has also proposed roles for 
cerebellum in anxiety and neuropsychiatric disorders, such as schizophrenia (reviewed in 
Baldacara et al., 2008). The cerebellum receives afferent connections from a variety of CNS 
structures. Information is gathered from the cerebral cortex through relay nuclei in the 
brainstem, including the olivary and pontine nuclei and these signals arrive via the middle 
cerebellar peduncle. Information from the spinal cord and the brainstem itself enters via the 
inferior cerebellar peduncle (Kiyohara et al., 2003).  The main outputs of the cerebellum 
target the cerebral motor cortex and the brainstem via deep cerebellar nuclei (Bengtsson et 
al.,  2004).  The  central  units  of  cerebellar  processing  are  the  Purkinje  cells  (PC),  which  are  
situated in the cerebellar cortex in a monolayer between the white matter and the granule cell 
layer. PCs receive inhibitory innervation from molecular layer interneurons (MLI), mainly 
basket and stellate cells, and excitatory innervation from granule cells and inferior olivary 
neurons (reviewed in Ito, 2000). As in the cerebral cortex and other forebrain areas, 
cerebellar basket cells produce dense interconnected formations around the somata of 
principal cells, in addition to forming a plexus around the axon initial segment. Stellate cells 
innervate the dendritic regions of PCs (Briatore et al., 2010). MLIs supply feed-forward and 
lateral  inhibition  of  PCs  and  thus  control  their  firing  rate,  timing  and  spread  of  action  
potentials.  
 
Forty percent of all inhibitory synapses in the molecular layer are between MLIs. It has been 
estimated that a single PC receives ~1500 inhibitory synapses from stellate cells, but PC 
recurrent collaterals in their turn only rarely contact MLIs (Briatore et al., 2010). MLIs are 
required for cerebellum-dependent behaviors, including motor learning, as they provide a 
tight control of input-output relations of PCs (Kondo and Marty, 1998). In the cerebellar 
cortex, connections between MLIs may induce fast (150-200 Hz) oscillations of PCs to 
enable encoding of information, in a similar manner that inter-interneuronal connections in 
forebrain areas influence networks of pyramidal neurons (Maex and De Schutter, 2005). 
Another possible function for connectivity between MLIs is that the reciprocal interaction 
represses inhibition during periods of strong parallel fiber activity to return the network to 
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baseline level. This would induce the stabilization of the firing rate of the interneuronal 
network and enable the maintenance of the network in optimal operational range to respond 
to the subsequent input (Briatore et al., 2010). 
  
Figure 2. Cerebellar circuits. P Purkinje cell, SC stellate cell, BC basket cell, Gr granule cell, pf 
parallel fiber, mf mossy fiber, cf climbing fiber, G Golgi cell, IO inferior olive, RN red nucleus, PN 
precerebellar nuclei, DCN deep cerebellar nuclei. + parvalbumin-positive cell. Black dots denote 
synapses. (Modified from Ito, 2000).  
 
PCs receive excitatory innervation from the axons of granule cells, which are in turn 
innervated by mossy fibers from extracerebellar nuclei. Granule cell axons, called parallel 
fibers, synapse on the dendrites of PCs, with up to 175000 connections per single PC (Isope 
and Barbour, 2002). In contrast to this high convergence, climbing fibers from the inferior 
olive, the other important source of excitatory innervations to PCs, usually contact only one 
PC, although the number of junctions between a climbing fiber and a PC may be as high as 
26000 (reviewed in Ito, 2000). The exact mechanism of cerebellar learning has received 
much attention, and already decades ago (Crepel and Krupa, 1988) it was proposed that 
climbing fibre activity reduced the power of the parallel fibre-PC synapse in a phenomenon 
called cerebellar long-term depression (LTD), leading to long-lasting alterations in the circuit 
(Welsh et al., 2005). Depression of the excitatory influence of parallel fibers onto PCs causes 
decreased activity of PCs, which in turn disinhibits deep cerebellar nuclei, which are under 
inhibitory control by PCs (reviewed in Uusisaari and De Schutter, 2011). 
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Figure 3. Layers of the cerebellar cortex. P Purkinje cell, B basket cell, Gr granule cell, G Golgi 
interneuron, IO inferior olive, DCN, deep cerebellar nuclei, PN precerebellar nuclei, pf parallel fiber, cf 
climbing fiber, mf mossy fiber. + excitatory synapse, - inhibitory synapse. (Modified from Wisden et al., 
1996).  
 
2.3.1 Cerebellar mutant mice 
 
A number of cerebellar mutant mouse lines have been described and found to be of use in 
characterizing the function of cerebellar circuits and cell types [e.g. the pcd (Mullen  et  al.,  
1976), wv, ”weaver” (Lane et al., 1977), tgla, ”leaner” (Herrup and Wilczynski, 1982), nr, 
“nervous” (Landis, 1973), sg,”staggerer” (Sidman et al., 1962) and Lc, “lurcher” (Caddy 
and Biscoe, 1979) mouse lines]. Most of these have focused on the role of PCs in the control 
of movement. These mutations cause the PCs to be wholly or partially destroyed, leading to 
degeneration of both efferent (deep cerebellar nuclei) and afferent (granule cells, olivary 
nuclei) targets due to lack of innervation and target deprivation, in addition to sizeable 
decreases in cerebellar volume (reviewed in Grusser-Cornehls and Baurle, 2001). In some 
mutants, the cells primarily affected are the granule cells, but reciprocal destruction of PCs 
follows, pointing to a mutual dependence and interconnectedness during development. 
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Depending on the exact mechanism and time point of PC and/or granule cell destruction, the 
mutant mice exhibit a variety of movement and gait abnormalities, ranging from mild ataxia 
to inability to perform independent locomotion (Baurle et al., 1998). The degree of 
destruction of PCs is not linear with symptom severity, as mice with near complete loss of 
PCs may suffer from milder deficits than those animals with ~50% of PCs surviving. This 
phenomenon points to downstream alterations and compensatory mechanisms and some 
degree of inhibition being restored to deep cerebellar nuclei in mice with complete 
destruction of PCs, most likely by a compensatory increase of calcium-binding proteins, 
which does not appear to occur before 90% of PCs are lost (Baurle et al., 1998). In mice with 
a significant amount of surviving PCs, the signaling from PCs to deep cerebellar nuclei is 
apparently so profoundly disorganized that the removal of the whole cerebellum actually 
improves the motor status of the mice (Grusser-Cornehls et al., 1999). Another problem 
inherent in these cerebellar mutant models is that the mutations are not necessarily restricted 
to the cerebellum; there may also be alterations in other brain areas, which confounds the 
interpretation of the observed defects. If it were possible to rapidly and reversibly modulate 
the activity of selected cerebellar cell types, e.g. the Purkinje cells in vivo, this would give 
valuable  insights  to  the  real-time  involvement  of  the  output  of  the  cerebellar  cortex  to  the  
deep cerebellar nuclei. 
 
2.4 The GABAA receptor 
 
?-Aminobutyric acid (GABA) is the most important inhibitory transmitter in the mammalian 
brain. It is synthesized in the nerve terminals of GABAergic neurons from glutamate by the 
two isoforms of glutamic acid decarboxylase (GAD) and it is stored in vesicles to await 
release into the synaptic cleft. When an action potential causes GABA be released into the 
synapse, the transmitter binds to its receptors in the synaptic membrane of the postsynaptic 
neuron (reviewed in e.g. Farrant and Nusser, 2005). After it has exerted its effects, GABA´s 
actions are terminated by uptake into the presynaptic neuron or glial cells, or it can be 
metabolized via GABA transaminase. In addition to synaptic transmission, low 
concentrations of GABA drifting out of the synapse can activate extrasynaptically located 
GABAA receptors. A low, ambient GABA concentration of below 300 nM is constantly 
maintained in the extracellular environment and contributes to tonic, extrasynaptic inhibition 
(Santhakumar 2006). 
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The effects of GABA are mediated through three types of receptors: GABAA, a ligand-gated 
ion-channel; GABAB,  a  G-protein  coupled  receptor  and  GABAC, an ion channel chiefly 
restricted to the retina. Of these three, the GABAA receptor is the most widespread; it is 
expressed ubiquitously in almost all brain areas and in the spinal cord, in addition to 
peripheral tissues, in a variety of different cell types. The presence of GAD is a useful 
neuronal marker for visualizing the location of GABAergic neurons. Due to its fundamental 
role in the inhibitory/excitatory balance of the CNS, GABA plays a role in a variety of 
neurological and psychiatric illnesses (reviewed in e.g. Gonzalez-Burgos et al., 2010; 
Macdonald et al., 2010). Many pathophysiological states, ranging from insomnia, anxiety and 
epilepsy to schizophrenia, have been shown to be linked to disturbances or abnormalities in 
the GABA system, whether from genetic alterations in the structure of the channel proteins or 
reduced amount of the transmitter in brain areas controlling integration of sensory 
information. 
 
The GABAA receptor is a member of the Cysteine-loop ligand-gated ion channel family, a 
anion channel protein consisting of 5 subunits (Lo et al., 2008). It is targeted to the surface 
membrane of the postsynaptic neuron at or near the synapse and upon agonist binding, it 
opens to allow the flow of Cl- or other anions either into or out of the neuron to hyperpolarize 
or depolarize the cell. The direction of the current depends on the physiological state of the 
network, outflow occurring during development (reviewed in Wang and Kriegstein, 2009) 
and certain pathophysiological states, e.g. some forms of epilepsy (Isomura et al., 2003). The 
exact three-dimensional structure of the receptor has not yet been directly established, but 
good approximations have been obtained through comparisons with the acetylcholine binding 
protein (Brejc et al., 2001), a structure with close homology to the GABAA receptor. Each 
subunit of the receptor weighs ca 50-60 kDa and comprises an N-terminal extracellular 
domain, a transmembrane domain and a cytoplasmic domain. Agonist binding takes place in 
the  extracellular  portion,  at  the  interface  of  ? and  ? subunits  (Ramerstorfer  et  al.,  2011),  
where a conformational change is triggered, leading to the opening of the channel gate in the 
transmembrane domain (Lo et al., 2008).  
 
2.5 GABAA receptor subunits  
 
Nineteen different subunits of the GABAA receptor have been identified so far, divided into 8 
subunit classes: ?(1-6), ?(1-3), ?(1-3), ?, ?, ? and ?, in addition to ?1-3, this final form mainly 
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expressed in the retina, where they create GABAC receptors. They share a protein sequence 
homology of 70-80% within the subunit class and 30-40% between classes (reviewed in e.g. 
Macdonald and Olsen; 1994, Olsen and Sieghart, 2009). Some subunits, like ?1, are 
ubiquitously expressed, while others, e.g. ?1, have a distinct, restricted regional expression 
pattern. The generation of knockout mouse lines with ablations of specific subunits 
(discussed in later sections) has provided many revelations on the significance of the subunits 
to the rules of receptor assembly and function. The presence of two ? subunits, along with 
two ? subunits, is essential for the formation of functional GABAA receptors,  as  the  two  
GABA binding pockets are situated at the interface between an ? and a ? subunit.  
 
2.5.1 The ? subunits  
 
The  six  types  of  ? subunits  fundamentally  define  the  affinity  of  the  GABAA receptor for 
benzodiazepines and furthermore differentiate between the variety of effects of 
benzodiazepines. The amino acid H101, present in subunits ?1, ?2, ?3 and ?5 confers 
benzodiazepine sensitivity. In ?4 and ?6, there is an arginine at position 101, which renders 
these subunits insensitive to benzodiazepines (Wieland et al., 1992). ?1 is the dominant ? 
subunit, expressed in almost all areas of the CNS, in interneuronal subtypes as well as 
principal cells (Briatore et al., 2010). The ?2 and ?3 subunits have a more discrete pattern of 
expression, and their expression is generally at a lower level as compared to the ?1 subunit 
(Pirker et al., 2000). The ?2 subunit is linked to emotional behaviors due to its location in the 
amygdala (Low et al., 2000), and ?3 may have relevance in absence epileptic symptoms due 
to its enrichment in the reticular nucleus of thalamus, an area known to regulate 
thalamocortical oscillations (Schofield et al., 2009). The ?4 subunit is found in the thalamus 
and hippocampal granule cells, where it is usually coexpressed with the ? subunit and 
comprises an essential component of extrasynaptic, tonically active GABAA receptors 
(Belelli et al., 2005, Jia et al., 2008). It also confers a heightened sensitivity to neurosteroids 
(Belelli et al., 2002). The ?5 subunit has its greatest expression in the hippocampus, where it 
may  take  part  in  extrasynaptic  transmission  (Caraiscos  et  al.,  2004).  It  is  believed  to  be  
involved in cognitive tasks; ?5 knockout mice have improved performance in memory tasks 
(Collinson et al., 2002). The ?6 subunit is only expressed in the cerebellum and cochlear 
nuclei, where it confers unique pharmacological properties, such as greater sensitivity to 
GABA and insensitivity to benzodiazepines (Korpi et al., 1999). It is an essential component 
of cerebellar tonic extrasynaptic transmission (Brickley et al., 2001). 
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2.5.2 The ?, ?, ?, ? and ? subunits 
 
A ? subunit is required for the formation of functional GABAA receptors and it is involved in 
the surface expression, agonist binding and anesthetic sensitivity of the GABAA receptor. The 
type of the ? subunit may affect the subcellular localization of the receptor: whether it is 
targeted to the dendrites, cell body or axon of the neuron (Connolly et al., 1996), as well as 
the  affinity  of  the  receptor  for  certain  anesthetic  and  anticonvulsant  medications,  such  as  
etomidate and loreclezole (Wingrove et al., 1994; Hill-Venning et al., 1997), in addition to 
binding the benzodiazepine inverse agonist DMCM (Stevenson et al., 1995) and furosemide 
(Korpi et al., 1995). The ? subunit is closely associated with the ?4 and ?6 subunits, together 
with which it assembles to form mainly, though perhaps not exclusively, tonically active 
extrasynaptic receptors (Stell et al., 2003), although in hippocampal interneurons, the ? 
subunit also colocalizes with the ?1 subunit (Glykys et al., 2007). GABA may act as a partial 
agonist  in  ? containing  receptors,  while  other  GABA  site  agonists,  such  as  THIP,  are  full  
agonists (Brown et al., 2002; Saarelainen et al., 2008; Chandra et al., 2010). The 
physiological significance of subunits ?, ? and ? is unclear, and there are dissimilarities 
between species in the brain regions where they are expressed (Sinkkonen et al., 2000; Ranna 
et al., 2006). Overall their expression level is very low, but they may have important roles in 
discrete nuclei, like the locus ceruleus and some hypothalamic areas. 
 
2.5.3 The ? subunits 
 
A ? subunit is required for benzodiazepine modulation of the GABAA receptor. ?2 confers 
full sensitivity, whereas the presence of ?1 or ?3 subunits reduces the modulation by 
benzodiazepine site ligands as compared to ?2 (Herb et al., 1992; Benke et al., 1996). The ?1 
subunit has a very low overall expression level, with the greatest expression being found in 
the basal ganglia, basal and septal forebrain nuclei, restricted thalamic nuclei, central and 
medial nucleus of amygdala and the inferior olivary complex (Pirker et al., 2000). The tightly 
restricted expression pattern suggests discrete functions, e.g. the ?1 subunit has been 
suspected to be involved in hypothalamic regulation of sexual behavior (Nett et al., 1999). 
The pharmacological properties of benzodiazepines are changed in ?1 compared to ?2 
containing receptors. Zolpidem produces a weak negative modulation instead of the classical 
positive modulation (Nett et al., 1999), and vice versa DMCM is positively, instead of 
negatively modulating (Puia et al., 1991).  
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The ?2 subunit is one of the most widely investigated of all the GABAA receptor subunits due 
to its multiple functions, ubiquitous expression and clinical significance with regard to 
benzodiazepine pharmacology. There are two splice variants, ?2S and ?2L, which differ by 
only eight amino acids. Despite the differences in their expression levels during development 
and some regional variation in adult animals, the two variants seem to be interchangeable 
(Boileau et al, 2010) and the overexpression of either one produces few phenotypic changes 
(Wick et al., 2000). Knockout of the ?2 subunit leads to massive neonatal mortality, with few 
animals surviving beyond a couple of days and displaying severe neurological abnormalities 
(Günther et al., 1995). Electrophysiological experiments have confirmed that receptors 
without the ?2 subunit are fully functional but have a lower GABA half-maximal effective 
concentration (EC50) and reduced single channel conductance (Lorez et al., 2000). Their 
GABA sensitivity is increased, but they convey smaller currents. Considering the fact that the 
brain morphology and endocrinology of ?2 knockout mice are normal, and that functional 
GABAA receptors are formed and transported to the cell surface, the ?2 subunit does not 
seem to be required for receptor assembly, transport, insertion into membranes, subcellular 
targeting or clustering of the GABAA receptors (Günther et al., 1995). Instead it is obligatory 
for the development of inhibitory circuits; the time frame of death of the ?2 knockout animals 
coincides with the period for synaptogenesis. The ?2 subunit targets the GABAA receptor to 
the synapse, and is required for the formation of GABAergic synapses (Essrich et al., 1998). 
Mice heterozygous for the presence of the ?2 subunit are viable but display phenotypic 
changes, including heightened neophobia and enhanced fear learning, as well as decreased 
amounts of synaptic clusters of GABAA receptors (Crestani et al., 1999). This 
haploinsufficiency implies that in wild-type neurons there is no excess amount of ?2 subunit.  
 
The ?3 subunit  is  the least  widely expressed of the three ? subunits.  The olfactory bulb,  the 
basal forebrain including the hypothalamus, midbrain, pons and medulla harbor the most 
expression of the subunit, though nonetheless at a low overall level (Pirker et al., 2000). The 
?3 subunit confers a benzodiazepine agonist sensitivity which is two orders of magnitude 
lower than the ?2 subunit, though the affinities of antagonists and inverse agonists remain 
approximately the same (Herb et al., 1992).  
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2.6 GABAA receptor assembly 
 
The rules governing the assembly into functional receptors of the 19 known GABAA receptor 
subunits have been a topic of intense study. The total number of possible combinations is 
exceedingly large, and even after establishing some basic rules of assembly, over 800 
different theoretical subtypes still exist, though the number of naturally existing subtypes is 
limited  by  temporal  and  cell-type  restriction  of  the  expression  of  subunits  available  for  
assembly (reviewed in Olsen and Sieghart, 2009). For some receptor subtypes there is 
definitive proof of expression in animal brain, for others the evidence is more tentative (Table 
1). There is by now universal agreement of the obligatory coassembly of two ? subunits, two 
? subunits and an additional subunit, usually ? or ?. This knowledge has been complemented 
with evidence from rarer, anatomically restricted subunits that may play unique physiological 
roles (reviewed in e.g. Ranna et al., 2006). The prevailing GABAA receptor subtype is 
thought  to  be  ?????2,  with  a  prevalence  of  43%  of  all  GABAA receptors in the CNS 
(McKernan and Whiting, 1996).  
 
A. Confirmed 
__________________________________________________________ 
?????2 ????2 ????2 ????? 
????2 ????? ????2 ? 
????2 ????? ????? 
__________________________________________________________ 
B. High probability of existence 
__________________________________________________________ 
?????2 ?????2 ?? 
???? ?????????? ????????????? 
___________________________________________________________ 
C. Possible 
___________________________________________________________ 
?1 ???1 ??? 
?2 ???1 ??? 
?3 ??? ??????2 
 
Table 1. GABAA receptor subtypes proposed to exist in vivo. (Modified from Olsen and Sieghart, 
2009). 
 
2.7 Synaptic and extrasynaptic inhibition 
 
Fast synaptic inhibition is a temporally precise inhibitory function that targets specific areas 
of the postsynaptic neuron. It occurs through quantal release of transmitter from the 
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presynaptic neuron in response to an action potential. Transmitter molecules are stored in the 
presynaptic terminal and are released by a mechanism of various recognized classes of 
proteins involved in the priming, docking and fusion of transmitter vesicles to the neuronal 
surface membrane to achieve release of the transmitter into the synaptic cleft (Delgado-
Martinez et al., 2007). The GABA concentrations produced in this way are present in the 
millimolar range, with every vesicle containing several thousands of GABA molecules. The 
released  transmitter  is  received  into  the  postsynaptic  density  of  the  synaptic  bouton  of  the  
postsynaptic neuron, where it may bind to various receptors and subsequently may modulate 
the  activity  of  the  neuron.  Synaptic  transmission  is  fast,  usually  on  a  time  scale  of  
milliseconds; the neurotransmitter effect can be terminated by the diffusion of the transmitter 
out of the synapse, its breakdown into metabolites, its disengagement from the receptors or 
by receptor desensitization (reviewed in Farrant and Nusser, 2005). In the GABAergic system 
synaptic receptors require the ?2 subunit to be correctly targeted to a postsynaptic localization 
and anchored there by the synaptic protein gephyrin, possibly by direct protein-protein 
interactions (Essrich et al., 1998). Some receptors containing the ?2 subunit can also be found 
located peri- or extrasynaptically, but the majority of GABAA receptors outside synapses are 
of the binary ?? type or ??? receptors (Brickley et al., 1999; Mortensen et al., 2010). The ?2 
subunit confers synaptic receptor properties missing from ?? receptors: benzodiazepine 
sensitivity, a lower affinity for GABA and a higher conductance (Hevers and Lüddens, 1998).  
 
The characteristics typical of extrasynaptic inhibition compared to synaptic inhibition are 
lower GABA EC50 values, reduced current amplitudes, slower desensitization and absence of 
fast desensitization, in addition to increased outward rectification (Belelli et al., 2009; Bright 
et al., 2011). Peri- and extrasynaptic receptors are activated by high nanomolar, ambient 
GABA  concentrations  that  are  attributable  to  GABA  drifting  out  of  the  synapse  after  fast  
synaptic transmission. This type of inhibition is also called tonic, to designate the stable, 
background nature of extrasynaptic inhibition, although it is nevertheless subject to dynamic 
modulation by physiological events and pharmacological treatments (reviewed in Farrant and 
Nusser, 2005). Tonic inhibition is believed to maintain inhibitory equilibrium during and in 
the absence of fast, synaptic events and so to regulate the overall GABAergic tone of many 
brain areas. Considering that extrasynaptic receptors may be spread throughout the surface 
membrane of the neuron, as opposed to the minimal surface area occupied by from tens to 
some hundreds of synaptic receptors, it becomes evident that extrasynaptic transmission is 
able to carry more charge transfer than synaptic transmission. It is estimated that there is a 
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threefold overall difference in charge transfer, and it follows that extrasynaptic inhibition is a 
fundamental element in the control of neuronal excitability. First discovered in the cerebellar 
granule cells (Brickley et al., 1996), it has since been shown to play many roles e.g. in the 
development of absence epileptic discharges in the thalamus (Belelli et al., 2009) and is 
involved in mediating the effects of neurosteroids and various other classes of GABAergic 
drugs (excluding the benzodiazepines).  
Figure 4. Synaptic and extrasynaptic transmission in a GABAergic synapse. A Transmitter release 
from a vesicle activates synaptic GABAA receptors. B Release from multiple vesicles or terminals 
results in transmitter spillover and activates also extrasynaptic receptors. C Tonically active high-
affinity extrasynaptic receptors respond to low, ambient concentrations of GABA. GAT1, GAT3: GABA 
transporter proteins. (Modified from Farrant and Nusser, 2005).  
 
2.8 Ligand binding sites of the GABAA receptor 
 
The GABAA receptor harbors binding sites for a number of substances which can modulate 
its activity, many of which have marked clinical significance. Two similar agonist binding 
sites are situated at the interface between ? and ? subunits (Ramerstorfer et al., 2011) and 
exist in all known receptor subtypes, also in binary receptors. In addition to the natural 
agonist GABA, the site binds several experimental agonists such as muscimol, THIP, and 
isoguvacine, as well as antagonists such as bicuculline. The affinity of some agonists, e.g. 
muscimol and THIP, is dependent on the subunit composition of the receptor; unlike GABA, 
they have a higher efficacy at ?4 and ?6 containing receptors (Winsky-Sommerer et al., 
2007). The exact sequence of conformational changes that occurs after the activation of the 
agonist binding site to the opening of the channel pore has been under vigorous investigation 
for many years, but is still not completely understood. It is currently considered most likely 
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that the changes proceed in a stepwise manner instead of a single hinge-or pivot-like 
alteration of the component parts of the channel in relation to each other (Kash et al., 2004). 
 
The  cage  convulsant  TBPS,  as  well  as  other  members  of  the  related  group  of  convulsants  
with a cage-like chemical structure, binds to the picrotoxin-sensitive convulsant binding site 
in the channel pore (Korpi et al., 1996), and this can be used as a pharmacological tool for 
investigating the properties and functional mechanics of the GABAA receptor. Radiolabeled 
[35S]TBPS  binds  to  all  conformations  and  subtypes  of  the  receptor  and  is  displaced  by  the  
natural ligand GABA in a concentration-dependent manner (Luddens and Korpi, 1995). The 
GABA-induced displacement can be modulated bidirectionally by GABAergic substances: 
ligands  which  enhance  the  actions  of  GABA  decrease  [35S]TBPS binding and conversely 
ligands which decrease the actions of GABA increase [35S]TBPS binding (Maksay and 
Simonyi, 1986). In addition to offering a way to quantify pharmacological effects at the ex 
vivo level, [35S]TBPS binding is a feasible technique to assess the levels of GABAA receptors 
in various brain areas. It is a flexible method and can be used in a variety of assays, ranging 
from those based on recombinant receptors and homogenized whole-brain membrane 
preparations to experiments with frozen slices of brain tissue. 
 
 
Figure 5. A topside view of the GABAA receptor. Five subunits center around a Cl- channel pore. Two 
GABA binding sites (G) are located between ? and ? subunits, and a benzodiazepine binding site (B) 
is formed between an ? and a ? subunit. 
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2.8.1 The benzodiazepine site 
 
The class of GABAergic substances with currently the most clinical significance and 
consequently the subject of the most research effort, is the benzodiazepines. Their spectrum 
of effects ranges from mild sedation to full hypnosis, giving rise to a variety of medical 
indications: anxiety, insomnia, status epilepticus and preoperative care etc. The allosteric 
benzodiazepine binding site of the GABAA receptor is situated at the interface between the ? 
and ? subunits. The ?2 subunit is required for benzodiazepine sensitivity, receptors with ?1 or 
?3 having a significantly lower or nonexistent sensitivity (Herb et al., 1992; Khom et al., 
2006). When binding to this allosteric site, benzodiazepines increase the opening frequency 
of the channel and so increase the apparent affinity of GABA for the receptor (reviewed in 
Sigel and Luscher, 2011). In the absence of the natural ligand, benzodiazepines have no 
effect on the receptor and as such have low toxicity. The chemical variety of substances that 
have affinity for the benzodiazepine site is large, but they can be divided into three groups 
according to effect. Agonists of the site (also called positive modulators) enhance the effects 
of GABA and have anxiolytic, sedative-hypnotic, anticonvulsant, amnesic and muscle 
relaxant actions. Inverse agonists decrease the effects of GABA by lowering the opening 
frequency of the channel and produce the opposite effects, including anxiogenesis, 
heightened vigilance and convulsions. Antagonists have no intrinsic effect on the activity of 
the receptor even at high concentrations, but negate the effects of both agonists and inverse 
agonists (reviewed in Olsen and Sieghart, 2009).  
 
The benzodiazepine binding site has been highly conserved during evolution, with several 
amino acids in the ? subunit, in addition to at least two in the ?2 subunit, having been 
identified as being essential for its structure. Despite the similarities in the sequences of ? 
subunits, it has been possible to develop subtype selective ligands of the benzodiazepine site, 
which have significantly more affinity for or efficacy in only a distinct subset of GABAA 
receptors (Savic et al., 2010). These have provided valuable insights into the influence of the 
receptor subtype on the pharmacological profile of the receptor. Pharmacological and genetic 
experiments have established that sedation/hypnosis and anticonvulsive activities are largely 
mediated through the ?1 subunit (Crestani et al., 1999), anxiolysis and muscle relaxation 
through ?2/?3 (Low et al., 2000) and amnesia through the ?5 subunit (Collinson et al., 2002). 
Subunits ?4 and ?6 are insensitive to benzodiazepines due to the presence of an arginine 
instead of histidine at position 101 (Dunn et al., 1999). A number of the benzodiazepine site 
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ligands with some subtype selectivity have shown either clinical or experimental utility. 
Zolpidem is a widely used sedative-hypnotic with high affinity for ?1 subunit containing 
receptors (Crestani et al., 2000). L-838,417 and TPA023 are relatively new compounds with 
equal affinity for all of the benzodiazepine sensitive ? subunits (?1, ?2, ?3 and ?5), but 
efficacy only at ?2/?3 containing receptors (Scott-Stevens et al., 2005; Ator et al., 2010). L-
655,708 has an inverse agonist action at ?5 containing receptors and has been shown to 
enhance cognition (Martin et al., 2009). These subtype targeted substances are selectively 
aimed at producing only some of the many effects of classical benzodiazepines, avoiding 
others which are perceived as unwanted, even harmful, depending on the treatment modality. 
 
Figure 6. A homology model of the benzodiazepine binding site of the GABAA receptor: the 
extracellular domains of ?1 and ?2 subunits indicating the ligand binding pocket. The bottom of the 
figure corresponds to the C-terminal end of the extracellular domain. Amino acid residues ?1H101, 
?1Y209 and ?2F77 are highlighted. (Reproduced from Ogris et al., 2004 with permission).  
 
2.8.2 The loreclezole site 
 
Loreclezole is a broad-spectrum anticonvulsant which binds to a ? subunit dependent site on 
the GABAA receptor. The actions of loreclezole do not require the presence of the ?2 subunit, 
which is needed for benzodiazepine effects, and as such it is likely to be present in all 
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GABAA receptors, also those with the binary ?? composition. Receptors with ?2/?3 are more 
sensitive to loreclezole than receptors with ?1 with about 300-fold difference in affinity 
(Wingrove et al., 1994). Two of the key amino acids present in this site are N289 and N265 
in the channel lining TM2 region; when the asparagine is mutated to serine, there is a marked 
loss of sensitivity (Wingrove et al., 1994; Stevenson et al., 1995). One of the other substances 
that has been shown to share the same binding site is the ?-carboline structured convulsant, 
DMCM. Though better recognized as a full inverse agonist of the benzodiazepine binding site 
with high nanomolar affinity, DMCM has low micromolar affinity in vitro (Stevenson et al., 
1995) and ex vivo (Makela et al., 1997) also at the loreclezole site, where its effects are 
GABA-potentiating. The phenomenon was first investigated in cerebellar ?6 subunit 
containing receptors, which are naturally insensitive to effects mediated via the 
benzodiazepine site, and the results have subsequently been confirmed with recombinant 
receptors. One interesting question is whether this agonistic effect could also be produced in 
vivo in conscious animals without concurrently invoking the strong inverse agonism of 
DMCM. In addition to DMCM, other ?-carbolines like ?-CCE also have affinity for this low-
affinity site. The report of Walters et al., (2000) speculated that even classical 
benzodiazepines like diazepam may have some affinity to the low micromolar site, in 
addition to their more traditional effects. This could be a possible mechanism for the 
anesthetic effects of diazepam at high doses, and also makes the low affinity site an 
interesting target for the development of novel GABAergic substances. Since it is likely to be 
present also in binary, extrasynaptically located receptors, substances binding there would 
also affect tonic inhibition.  
 
2.8.3 Other binding sites 
 
Barbiturates, a class of drugs previously widely used for sedative and hypnotic and anti-
convulsant purposes, have two binding sites in the GABAA receptor, an allosteric modulatory 
one, where barbiturates increase the open time of the channel, but do not increase the opening 
frequency or probability, and a directly activating one, where at high concentrations, they are 
able to activate the channel by themselves (Serafini et al., 2000). Amino acid residues in the ? 
subunit are known to be essential for the actions of barbiturates (Serafini et al., 2000). 
Neuroactive steroids also have both modulatory and directly activating effects at the receptor 
and are assumed to have two separate binding sites. In addition, there are reports of certain 
neurosteroids having a negative modulatory effect, perhaps via yet another binding site (Akk 
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et al., 2001). Volatile anesthetics, e.g. halothane, were previously believed to exert their 
inhibitory effect on the CNS via a nonspecific modulation of the lipid bilayer of the neuronal 
membrane, but they have since been shown to have a specific binding site in the GABAA 
receptor (Werner et al., 2011). Intravenous anesthetics, like etomidate and propofol also have 
their own binding/effector site, which is common to the anticonvulsant loreclezole. Other 
minor binding sites in the GABAA receptor,  such  as  the  sites  for  zinc,  lanthanum  and  
furosemide, though not clinically relevant, can be used in experimental approaches to 
investigate the properties of the receptor (Korpi and Luddens, 1997). 
 
Ethanol is a clinically and epidemiologically significant substance of abuse, which binds to 
several targets in the CNS, among them the GABAA receptor. Much recent work has focused 
on its multiple binding sites in the GABAA receptor, especially a ?2 subunit-dependent site 
and a recently reported ? subunit-dependent one (Hanchar 2006). Some controversy has 
existed as to the mechanism of action of the partial benzodiazepine inverse agonist Ro 15-
4513 in reversing the receptor-mediated effects of ethanol, and as such the importance of the 
?2  subunit  as  a  site  of  action  of  ethanol.  Currently  it  seems  more  likely  that  at  least  the  
sedation caused by ethanol is mediated through the ?2-dependent and not the ?-dependent 
binding site (Linden 2011). 
 
2.9 The ?2I77 point mutation 
 
One of the amino acids present in the benzodiazepine binding site is phenylalanine (F)77 of 
the ?2 subunit. Point mutation studies have established that changes in this position, 
interestingly analogous to F64 in the GABA binding site of the ? subunit (Buhr et al., 1997), 
affect the binding of benzodiazepines. F77L, F77Y, F77W and F77I mutations have been 
created and shown to exhibit reduced affinities for a number of benzodiazepine-type 
substances to varying degrees depending on their chemical structures (Buhr et al., 1997). 
Classical nonselective benzodiazepines like diazepam and flunitrazepam mostly retain their 
affinities, but the affinity of some ligands like zolpidem, is reduced, as well as the affinity of 
the inverse agonist DMCM. In all of these mutations, the affinity of the receptor for GABA 
remains largely the same as in F77 containing receptors, and the coupling of the 
benzodiazepine site to the agonist site is intact, which implies that the functionality of the 
receptor has been preserved despite the point mutation (Buhr et al., 1997; Wingrove et al., 
45 
 
1997). The I77 mutation is particularly interesting, as there is an isoleucine instead of 
phenylalanine at position 77 in the ?1 subunit, which is insensitive to DMCM and zolpidem 
(Puia et al., 1991). The I77 mutation renders the ?2 subunit insensitive to triazolam, 
clonazepam, zolpidem, flumazenil, Ro 15-4513, DMCM and other ?-carbolines (Buhr et al., 
1997; Wingrove et al., 1997; Cope et al., 2004).  
 
A mouse line with the ?2I77 point mutation was generated and an electrophysiological, 
pharmacological and phenotypic analysis was performed (Cope et al., 2004). The ?2I77 mice 
were healthy and viable, they bred normally and had no phenotypic abnormalities in the 
SHIRPA behavioral screen. Furthermore, their gross brain morphology was unaltered. The 
expression levels of most GABAA receptor subunits in ?2I77 brains were normal, but there 
was  an  overall  15%  decrease  in  ?2  subunit  levels.   The  ability  of  zolpidem  and  also  
flumazenil to displace [3H]flunitrazepam binding was strongly reduced in ?2I77 brains, with 
only a slight reduction in the ability of flurazepam to displace the radioligand (Cope et al., 
2004). There were no differences in baseline synaptic currents of ?2I77 mice, but zolpidem 
was unable to enhance the peak amplitude, weighted decay, rise time or charge transfer of 
averaged miniature postsynaptic currents (mIPSCs), or the total current and frequency of 
mIPSCs in the cerebellar Purkinje cells, of ?2I77 mice, a cell type where both ?1 and ?2 
subunits are expressed (Cope et al., 2004). Zolpidem was administered to awake, freely 
moving ?2I77 mice in behavioral tests. Zolpidem at 3 mg/kg did not produce sedation in the 
staircase chamber in ?2I77 mice, whereas control mice were clearly sedated and failed to 
climb any stairs. In a rotarod test, a cumulative dosing of 1-30 mg/kg zolpidem did not impair 
the performance of ?2I77 mice. The effects of flurazepam on the rotarod performance of 
?2I77 mice were unaltered compared to wild-type mice (Cope et al., 2004). The effects of 
zolpidem were also strongly reduced in the hippocampus of ?2I77 mice, although slight 
residual effects were found to be present in that area (Cope et al., 2005). Ogris et al., (2004) 
performed an extensive study on the effects of a total of 24 substances from various classes of 
benzodiazepine binding site ligands on [3H]flunitrazepam binding in a membrane preparation 
of ?2I77 brains and confirmed that the ?2I77 mutation selectively affected only a few ligands 
acting through the benzodiazepine binding site. The greatest reductions in the ability to 
displace  [3H]flunitrazepam binding were found with zolpidem, flumazenil, the 
triazolopyridazine Cl 218872 and the ?-carboline DMCM (Ogris et al., 2004). The ?2I77 
mouse line would be an interesting tool to further test in vivo the reductions in the effects of 
benzodiazepine ligands,  as well  as the residual effect  of zolpidem observed by (Cope et  al.,  
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2005) and the positive modulating effect of DMCM observed in vitro by  (Stevenson  et  al.,  
1995). 
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3 AIMS OF THE STUDY 
 
The purpose of these studies was to develop a method for the fast, reversible modulation of 
specific neuronal populations and to use that method to clarify the significance of selected 
neuron types to the overall function of the CNS. Pv-positive neurons and cerebellar Purkinje 
cells form integral parts of complex networks for the control of diverse behavioral modalities, 
the details of which are incompletely known. By modulating the activity of one cell type of 
the network in genetically altered mouse models, new information on the roles of the 
particular cell types to the network and behavior of the animal could be obtained. In addition, 
it was wished to use the background ?2I77 mouse line to explore the possible residual actions 
of GABAA receptor benzodiazepine binding site ligands at other, low affinity binding sites 
uncovered by the point mutation in the ?2 subunit of the receptor. Both in vivo and ex vivo 
methods were used to achieve these specific aims: 
 
1. To investigate whether the convulsant, GABAA receptor inverse agonist  DMCM and the 
subtype-selective hypnotic zolpidem have residual activity in ?2 subunit I77 point mutant 
mice mediated through non-benzodiazepine sites of action 
2.  To  analyze  the  significance  of  the  removal  of  the  GABAA receptor ?2 subunit from 
cerebellar Purkinje cells on mouse behavior 
3. To modulate cerebellar Purkinje cells in a fast and reversible manner to reveal their 
significance on mouse motor coordination 
4. To analyze the significance of the removal of the GABAA receptor  ?2 subunit  from Pv-
positive neurons on mouse behavior 
5. To modulate Pv-positive neurons in a fast and reversible manner to reveal their 
significance on mouse behavior   
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4 MATERIALS AND METHODS 
 
4.1 Experimental animals  
 
All animal experiments were approved of by the Southern Finland Provincial Government 
and  the  Institutional  Animal  Use  and  Care  committee  of  the  University  of  Helsinki.  All  
efforts were made to minimize the number and suffering of animals used. C57BL/6J (n=35), 
wild type ?2F77 (n=22), heterozygous ?2F77/ ?2I77 (n=4), ?2I77 (n=196), Pv-??2 (n=16), 
Pv-??2-partial rescue (n=36), PC-??2 (n=26) and PC-?2-swap (n=22) mice of both sexes 
were used. In all behavioral experiments the individual who observed and recorded the 
behavior was blind to the genotype of the animals 
 
4.1.1 Generation of mouse lines 
 
The genetically engineered mouse lines were generated by collaborators as described below 
in the original references: For the ?2I77 line, bacterial artificial chromosome (BAC) mediated 
recombination was performed in mouse embryonic stem cells to replace the wild type F77 
codon with the I77 codon (Cope et al., 2004). For the Pv-??2 line, mice with loxP-site 
flanked GABAA receptor ?2I77 subunits were crossed with mice expressing Cre recombinase 
in Pv-positive cells; correct expression of transgene was ascertained with 
immunohistochemistry for parvalbumin and in situ hybridization probes for parvalbumin and 
the ?2 subunit (Wulff et al., 2009a). For the Pv-??2-partial rescue line, two transgenes were 
co-integrated by mixing and co-injection of two BACs into pro-nuclei of mouse embryonic 
stem cells; the resulting mouse line was crossed with mice expressing the loxP-flanked ?2I77 
subunits. Expression of the transgene was ascertained with in situ hybridization (IV). For the 
PC-??2 line, mice with loxP-flanked GABAA receptor ?2I77 subunits were crossed with 
mice expressing Cre recombinase in cerebellar Purkinje cells (III). For the PC-?2-swap line, 
a triple cross between loxP-flanked ?2I77 subunit mice, mice expressing Cre recombinase in 
Purkinje cells, and mice with green fluorescent protein (GFP)-tagged wild type F77 subunits 
expressed in Purkinje cells was performed. Expression of transgene was ascertained with in 
situ hybridization and immunohistochemistry (III). 
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4.2  Culturing and transfection of HEK-293 cells 
 
Human embryonic kidney (HEK-293) cells are a widely used, feasible method of expressing 
many types of proteins in the cellular surface membrane. They can be utilized e.g. in the 
electrophysiological analysis of ion channel activity and the functions of transport proteins, in 
addition to autoradiographic experiments.  
 
HEK-293 cells were passaged and replated on plastic dishes, which were filled with medium 
and supplemented with sodium bicarbonate, glutamine, penicillin-streptomycin and fetal calf 
serum. Cultures were maintained at 37°C in a humidified atmosphere for 2-3 days. 
Transfection with recombinant rat GABAA receptors was carried out as described in detail in 
(Korpi and Lüddens, 1993). For the identification of transfected cells for electrophysiological 
recordings peGFP-N1 vector was added. HEK-293 cells were used for ligand binding 
autoradiography and electrophysiological experiments (II). 
 
4.3 Ligand autoradiography and binding assays 
 
GABAA receptor ligands labeled with a radioactive isotope can be used to visualize the 
amount  and  location  of  the  receptor  in  the  brain.  The  ionophore,  convulsant  binding  site  is  
recognized by several radioligands, e.g. the picrotoxin-sensitive [35S]t-
butylbicyclophosphorothionate ([35S]TBPS), a cage convulsant which binds inside the Cl- 
channel pore. [35S]TBPS binding can be modulated with GABAergic substances: compounds 
which enhance the effects of GABA decrease [35S]TBPS binding whereas, conversely, 
compounds which decrease GABA effects enhance [35S]TBPS binding. The assay provides a 
good way to evaluate the actions of various substances at the receptor level; in addition to 
bidirectional modulation there is also good regional resolution (Maksay and Simonyi, 1986; 
Makela et al., 1997).  
 
Another radioligand useful in these studies is [3H]Ro 15-4513, which labels the flumazenil-
sensitive benzodiazepine binding site of the GABAA receptor. Its binding is dependent on the 
presence of the wild-type ?2 subunit and it can be displaced competitively with other ligands 
which bind to the same site. The autoradiographic method can be used for homogenized brain 
samples or frozen cryostat sections. Although cell structure is lost by freezing, the receptors 
as well as gross anatomy remain intact (Sieghart et al., 1987; Uusi-Oukari, 1992). 
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4.3.1  [35S]TBPS autoradiography (I, II, IV) 
Cryostat sections were preincubated in an ice-water bath in an EDTA-containing 
preincubation buffer solution, after which the sections were dipped in the incubation buffer 
solution. The final incubation took place with [35S]TBPS in the incubation buffer at room 
temperature for 90 min. Nonspecific binding was determined with picrotoxinin. After the 
incubation, the sections were washed with wash buffer, dipped in distilled water and dried in 
air flow at room temperature. The sections were then exposed with [14C]-plastic standards to 
imaging plates or to radiosensitive films (Makela et al., 1997).  
 
4.3.2  [3H]Ro 15-4513 autoradiography (II, IV) 
 
Cryostat sections were preincubated in an ice-water bath in incubation buffer. The incubation 
took  place  with  [3H]Ro 15-4513 in the incubation buffer in the dark at 4oC for 60 min in 
plastic slide mailers. Nonspecific binding was determined with flumazenil. After incubation, 
the sections were washed with ice-cold incubation buffer, dipped in distilled water and dried 
under air flow at room temperature. The sections were then exposed with [3H]-plastic 
standards to imaging plates or to radiosensitive films (Makela et al., 1997).  
 
4.3.3 [3H]EBOB binding assay (II) 
Resuspended cell membranes were incubated in buffer solution. GABA was diluted in buffer 
and loreclezole in dimethylsulfoxide. The zolpidem and DMCM stock solutions were 
dissolved in ethanol. Non-specific binding was determined by picrotoxinin. After incubation 
at room temperature, the assay mixtures were rapidly diluted with buffer, filtered and washed. 
Filters were immersed in scintillation fluid and the radioactivity determined in a liquid 
scintillation counter using external standardization (Yagle et al., 2003).  
 
4.3.4 Quantification from films (I, II, IV) 
 
Representative images from autoradiography films were scanned using a scanner and suitable 
software. For quantification of binding densities, the scanned images were then analyzed. 
Binding densities for each brain area were referenced to the [3H]- or [14C]-standards, 
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converted to radioactivity levels estimated for gray matter areas (nCi/mg), and given as 
means ± SEM (Makela et al., 1997).  
 
4.4 In situ hybridization (III, IV) 
 
In situ hybridization is a protocol for visualizing radiolabeled proteins. It utilizes the 
construction of specific probes for known genomic sequences and the reaction of the probes 
with the target to produce a quantifiable signal, which is subsequently analyzed. 
 
In situ hybridization with [35S]-labeled oligonucleotide probes for ?2 subunit exon 4, eGFP 
and Cre recombinase was performed as described (Wisden et al., 1992). Images were 
generated from 10 week exposures to X-ray film. To assess non-specific labeling of the 
sections, each labeled oligonucleotide was hybridized to brain sections with a 100-fold excess 
of unlabeled oligonucleotide (Duncan et al., 1995).  
 
4.5 Immunohistochemistry (III, IV) 
 
Immunohistochemistry is a method for detecting the presence of proteins of interest by the 
immunological reaction of antibodies to their targets. The antibodies are raised against their 
target proteins in a different animal species and incubated with tissue samples. Fluorescent 
and  dye  labels  are  used  to  visualize  the  signal.  The  results  are  qualitative  rather  than  
quantitative.  
 
4.5.1 Enhanced green fluorescent protein (eGFP) imaging and ?-galactosidase staining 
(IV) 
 
Free-floating sagittal sections were washed in buffer, permeabilized and blocked by 
incubation in normal goat serum at room temperature and subsequently incubated with a 
rabbit polyclonal anti-eGFP primary antibody. Incubated slices were washed, incubated with 
a Cy3-conjugated goat anti-rabbit IgG, and subsequently washed. Slices were rinsed briefly, 
mounted on slides, embedded in embedding medium, cover-slipped, and analyzed using an 
upright fluorescent microscope. For ?-galactosidase staining, free-floating sections were 
incubated in 5-bromo-4- chloro-3-indolyl-?-galactoside (Mellor et al., 1998).  
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4.5.2 Triple labeling (III) 
 
For triple-immunofluorescence, free-floating sections were incubated in blocking solution. 
The sections were then incubated in primary antibodies: affinity purified rabbit antibody to 
the ?1 subunit, guinea pig antiserum to eGFP and sheep antibody to GAD. On the following 
day, the sections were rinsed thoroughly and then incubated in donkey anti-rabbit Cy5, 
donkey anti-sheep Cy3, and donkey anti-guinea pig Alexa 488. Finally, the sections were 
rinsed and mounted. The method specificity was tested by incubating sections in one primary 
antibody with the full set of three secondary antibodies and images were acquired at all 
wavelengths (Zezula et al., 1991).  
 
4.5.3 c-Fos expression (I, II) 
 
Brain sections were immunostained as described earlier (Linden et al., 2004). After 
paraformaldehyde fixation and hydrogen peroxide treatment, sections were incubated in 
blocking  buffer,  after  which  they  were  incubated  overnight  at  4?C in incubation buffer 
containing goat polyclonal anti-c-Fos antibody and on the next day, after several washes, 
with a biotinylated rabbit anti-goat IgG. Visualization was performed using avidin-
horseradish peroxidase and diaminobenzidine-nickel sulfate. Photomicrographs of sections 
were captured using a digital camera under a light microscope. An image-analysis software 
was used to measure mean optic density levels within the hippocampal dentate gyrus. 
 
4.6 Electrophysiology  
 
Electrophysiology deals with the electrical properties of neurons and other cells, and is a field 
of  various  methods  aimed  at  analyzing  the  electrical  activity  and  properties  of  cells  of  
interest. The available techniques range from the investigation of single ion channels on the 
cell surface to the mapping of whole networks of brain regions. Activity can be studied in 
artificial environments like ion channels expressed in cultured cell lines, in tissue slices from 
the brains of animals or even in alive, behaving animals. 
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4.6.1 Recordings from HEK 293 cells (II)  
 
Two days after transfection coverslips with HEK 293 cells were placed in a recording 
chamber mounted under a fluorescence microscope and perfused with a recording solution. 
Transfected cells were identified by their eGFP fluorescence. Membrane currents in these 
cells were studied in the whole-cell configuration of the patch-clamp technique (Rabe et al., 
2007). Data analysis was performed using the appropriate programs. The amplitudes of peak 
currents were measured from recorded traces. 
 
4.6.2 Recordings from brain slices (III) 
 
Adult mice were anaesthetized and decapitated. The brains were removed and dissected in 
cold oxygenated slicing solution, after which parasagittal slices were cut from the cerebellar 
vermis. After incubation, individual slices were transferred to a submerged recording 
chamber. Neurons were directly visualized under infrared differential interference contrast 
optics. Whole-cell patch-clamp recordings were performed (III).  
 
4.7 Behavioral studies 
 
The animal models of altered neuronal function used in these studies are based on the genetic 
manipulation of receptor properties. To confirm the changes at the cellular and receptor level, 
ex vivo methods like immunohistochemistry and autoradiography are most useful. However, 
the end point was at the whole animal level; the behavior of the mutant mouse reveals the 
degree of the success achieved with the model. To this end a wide array of behavioral 
paradigms  were  used,  ranging  from  the  SHIRPA  screen  which  assesses  gross  phenotypical  
changes, to more sophisticated tests like prepulse inhibition of the acoustic startle reflex, 
which is aimed at quantifying a specific deficit in sensorimotor integration. By not limiting 
the approach to only a few modalities it was hoped to gain a comprehensive picture of the 
phenotypes of these mutant mouse lines, and ultimately of the effect of the mutations on the 
networks which control these behaviors.  
 
  
54 
 
4.7.1 SHIRPA screen (IV) 
 
Basic behavioral and physiological characterization of phenotype was performed using a 
modified version (Vekovischeva et al., 2004) of the primary observational screen described in 
the  SHIRPA  protocol  (http://empress.har.mrc.ac.uk/browser/?sop_id=10_002_0). In the 
screen, animals were visually observed both in a confined space and moving freely. Their 
motor coordination and sensory perception were assessed and they were handled to provoke 
mild reactions. Simple measurements like body weight and body temperature were taken. 
Any abnormalities were compared to control mice screened at the same time under similar 
conditions. The animals were naïve to handling at the time of SHIRPA testing.  
 
4.7.2 Elevated plus-maze (I, IV) 
 
To investigate the basal anxiety level of the mice, an elevated plus-maze test was performed.  
The test utilizes the conflict between the innate tendency of rodents to explore their 
surroundings and the natural aversion they exhibit towards open, brightly lit spaces. The total 
time spent in and the entries made into the brightly lit open arms and the arms enclosed by 
the walls of the cross-shaped apparatus provide a measure of the anxiety state of the animals. 
In  a  state  of  heightened  anxiety  there  is  a  tendency  to  avoid  the  open  arms  and  stay  in  the  
enclosed arms; vice versa in a state of decreased anxiety.  
The test was performed after the primary SHIRPA screen, before any other tests. The 
apparatus was made of grey plastic and elevated from the floor level. It consisted of a central 
platform, from which two open arms and two enclosed arms extended (Lister, 1987). The 
mice were placed individually on the central platform facing an open arm and allowed free 
exploration of the maze with their behavior being recorded using an Ethovision video 
tracking system with a charge-coupled device video camera above the plus maze (Saarelainen 
et al., 2008).  
 
4.7.3 Open field exploration (II) 
 
The open field test can be used to assess the overall locomotor activity of rodents, as well as 
the effects of substances that affect the alertness level of animals. An alert animal placed in 
an open field for the first time will explore the arena. If the animal has been administered 
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stimulants, like amphetamine, it will move more compared to an unmedicated control animal, 
which can be detected automatically by a video camera and quantified by the attached 
software. In the case of sedative substances, locomotor activity is decreased. Deficits in 
motor coordination may also lead to a decreased level of locomotion (Carola et al., 2002).  
 
Mice naïve to the open field apparatus were placed individually in the center of an open 
arena. The mice were allowed free exploration of the arena and their behavior was recorded 
via  a  camera.  The  position  and  movements  of  the  center  of  the  animal’s  surface  area  were  
analyzed automatically with the Ethovision software (Linden et al., 2008). The number of 
rearing events was recorded manually from a monitor by an observer blind to genotype and 
pharmacological treatment. When pharmacological testing was conducted, a minimum wash-
out period of three days was kept between treatments. 
 
4.7.4 Startle reflex and prepulse inhibition (IV) 
 
The acoustic startle reflex is a measure of an animal’s reactivity to sudden, unexpected 
noises. On perceiving a loud noise, mice blink and flinch; the amplitude of the flinch is 
measured. The startle paradigm is primarily used to evaluate hearing, but various other 
factors, e.g. the anxiety state of the animal, may also have a bearing on the result. 
Disturbances in the oligosynaptic startle reflex circuit of the brainstem may also reflect in this 
paradigm (Plappert and Pilz, 2002). When a slight acoustic prepulse stimulus precedes the 
actual stimulus, the amplitude of the startle response is decreased in healthy mice. This is 
taken as an indication of sensorimotor gating, the ability of the brain to screen irrelevant 
stimuli from perception. Deficits in sensorimotor integration are a hallmark symptom in 
schizophrenic human patients, and many animal models of schizophrenia reproduce these 
deficits (Geyer and Braff, 1987; Andreasen et al., 2006). The predictive validity of the 
prepulse inhibition test in disease models is seen in its responsiveness to antipsychotics and 
psychotomimetics (Duncan et al., 2006). 
 
 The acoustic startle response and prepulse inhibition were measured using an automated 
startle system (Brody et al., 2004; Heldt et al., 2004). In an illuminated and sound-attenuated 
chamber, a small cage was mounted above a piezoelectric sensor. Background noise and 
acoustic stimuli were delivered through speakers in the ceiling of the chambers. First, 
acoustic startle responses to stimuli of different intensities were determined. An acclimation 
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period was followed by seven blocks of trials containing seven stimuli of different intensities 
in a pseudorandom order.  
 
After startle testing, prepulse inhibition was analyzed in trials, in which the startle stimulus 
was preceded by a prepulse stimulus. Antipsychotics and psychotomimetics were 
administered to investigate whether they could modulate prepulse inhibition. The percent 
prepulse inhibition was calculated from the formula: %PPI = [(amplitude of startle pulse 
alone – amplitude of startle pulse when preceded by a prepulse) / amplitude of startle pulse 
alone] x 100. 
 
4.7.5 Morris water maze (IV) 
 
Spatial reference memory, a hippocampal-dependent aspect of cognition, can be assessed in 
an environment where the animal learns to navigate to a given target by using external visual 
cues. Mice were trained for 4 days to find a platform submerged below the surface of a pool 
of water. Visual markers were placed on the walls of the experiment room to facilitate spatial 
learning. The escape latency, swimming velocity and total distance were recorded. One day 
after training, a probe trial was performed in which the platform was removed and the time 
the mice spent in the platform quadrant as well as the number of visits to the former platform 
position  and  the  swimming  velocity  were  recorded  (modified  from  Florian  and  Roullet,  
2004). 
 
4.7.6 Fear conditioning (II) 
 
A fear conditioning test utilizes the ability of a noxious stimulus, e.g. an electrical shock, to 
elicit  a  forceful  memory  trace.  During  the  conditioning  session,  where  two  shocks  are  
administered signaled by a cue sound, the animal acquires a freezing response when the cue 
is sounded, in anticipation of the shock. The acquisition of the memory trace can be 
bidirectionally modulated with substances affecting the different phases of memory formation 
(Sieve et al., 2001).  
 
On the conditioning day, mice were injected i.p. with 20 mg/kg DMCM or vehicle. Fifteen 
min post injection the animals were placed individually in test chambers, where they were 
allowed free exploration, after which a cue tone was created from wall-mounted speakers, co-
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terminating with a shock through the grid floor. The cue-shock pairing was repeated once. 
After a final exploration period, the mice were removed from the chambers and returned to 
home cages. On the testing day, the mice were placed in the test chambers and freezing to 
context was scored. After this, the context was altered and the mice were re-tested for 
freezing in the presence and absence of the cue tone. The amount of freezing from both 
conditioning and testing days was collected by an infrared video camera and automatically 
analyzed (Sieve et al., 2001). 
 
4.7.7 Hot plate and tail flick (IV) 
 
Pain can be divided to several different modalities, and accordingly different paradigms are 
used to test nociception. Two tests measuring thermal pain were utilized, the hot plate and the 
tail flick. Both tests are dependent on the ability of the mouse to react to a painful stimulus by 
physical movement. While the hot plate test measures a supraspinal reflex, the tail flick test is 
dependent on a spinal nociceptive reflex (Davidova et al., 2009; Kubo et al., 2009). The tail 
flick  test  was  chosen  to  supplement  the  hot  plate  test  also  because  of  the  motor  deficits  
observed in Pv-??2 and Pv-??2-partial rescue mice.  
 
During the hot plate test, the latency to react was scored visually when the mouse rapidly 
moved or licked its hindpaw or jumped. In the tail flick test, reaction latency was scored as 
the time before the tail withdrawal reflex. After DMCM administration, analgesic responses 
were measured (Linden et al., 2007).  
 
4.7.8 Tremor measurement (IV) 
 
Tremor can be either innate or induced by pharmacological substances (Milner et al., 1995; 
Handforth et al., 2010). Its two basic dimensions are frequency, which denotes the amount of 
oscillation in a given time period, and amplitude, which reveals the energy spent in tremor. 
Innate tremor is caused by a variety of factors, e.g. disturbances in the function of cerebellar 
circuits.  
 
The tremor measurement apparatus was developed in-house and consisted of a piezoelectric 
weight sensor with three independent measurement stations. On the test, day baseline 
58 
 
measurements were performed, after which mice were injected with harmaline, and tremor 
was measured.  
 
4.7.9 Electroshock convulsions and zolpidem (II) 
 
Electroshock-induced convulsions are known to produce a robust expression of the 
immediate early gene c-Fos in various brain areas. c-Fos expression is a marker of neuronal 
activity,  and  as  such,  its  expression  can  be  modulated  with  substances  that  increase  or  
decrease the actions of GABA. In order to study the inhibitory actions of the non-classical 
benzodiazepine zolpidem in hippocampal neurons, mice were given a short electroshock after 
saline or zolpidem administration. Electroshock-induced convulsions were produced by 
delivering current pulses via ear-clip electrodes from an electric unit. The animals received a 
single electroshock, after which they were decapitated. The brains were collected for analysis 
of c-Fos expression (Linden et al., 2004). 
 
4.7.10 Motor training (I, II, III, IV) 
 
Motor coordination is a complex function dependent on various brain areas, which affect 
different components of motor learning and performance (reviewed in Ito, 2000). One of the 
most important sites is thought to be the cerebellum, in which relatively well-defined 
networks govern the activity of output neurons in the deep cerebellar nuclei (reviewed in 
Uusisaari and De Schutter, 2011). Disturbances in cerebellar circuit function may affect the 
learning of motor tasks. Motor coordination can also be modulated with substances that act 
on the cerebellum. Mice were trained to stay on a rotating rod for three minutes and to walk 
along a thin wooden beam to their home cages (Korpi et al., 1999; Linden et al., 2008). After 
the animals had acquired the required motor skills, in order to study pharmacological 
sensitivities  to  GABAergic  substances,  they  were  injected  with  the  test  compounds  and  
performance evaluated on the rotarod and the walking beam. Latency to fall from the rotarod 
and time to cross the beam were measured. 
 
4.7.11 Statistical testing 
 
Mouse lines and pharmacological or behavioral treatments were compared with repeated 
measures ANOVA, two-way ANOVA, one-way ANOVA, Newman-Keuls, Dunnett, Mann-
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Whitney U, Wilcoxon signed rank, Fisher or Student’s t-test. The variance analyses were 
used to compare two or more treatment groups (genotype or pharmacological treatment, with 
single or multiple time points, drug doses or drug concentrations), and the post hoc test was 
chosen according to the type of data utilized. When only two groups were compared, the 
Student’s t-test or Wilcoxon signed rank test was used. 
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study mouse line method   aim of method 
I ?2I77 c-Fos expression  effects of DMCM 
  convulsion test  effects of DMCM 
  locomotor activity  effects of DMCM 
  rotarod   effects of DMCM 
  horizontal wire  effects of DMCM 
  elevated plus maze  effects of DMCM 
  staircase test   effects of DMCM 
II ?2I77 [3H] Ro 15-4513 autoradiography effects of DMCM and zol 
[35S] TBPS autoradiography  effects of DMCM and zol 
  [3H] EBOB autoradiography effects of DMCM and zol 
  electrophysiology in HEK-293 cells effects of DMCM and zol 
  open field    effects of DMCM and zol 
  rotarod   effects of zol 
  walking beam  effects of zol 
  fear conditioning  effects of DMCM 
  c-Fos expression  effects of zol 
III PC- ??2, in situ hybridization  expression of transgene 
 PC- ?2-swap immunohistochemistry  expression of transgene 
  whole-cell electrophysiology activity of Purkinje cells, 
     effects of zol 
  rotarod   effects of zol 
  walking beam  effects of zol 
IV Pv-??2, in situ hybridization  expression of transgene 
 Pv- ??2-pr immunohistochemistry  expression of transgene 
  [3H] Ro 15-4513 autoradiography expression of  ?2 subunit
  [35S] TBPS autoradiography composition of GABAA  
    receptors 
 SHIRPA screen  basic phenotype 
 elevated plus maze  anxiety level 
 acoustic startle  auditory reactivity 
 pre-pulse inhibition of startle sensorimotor gating 
 Morris water maze  spatial navigation 
 rotarod   motor coordination 
 walking beam  motor coordination 
 tremor   tremor activity 
 hot  plate    nociception 
 tail flick   nociception 
 motor pharmacology  effects of DMCM and zol 
    on motor coordination 
 
Table 2. The main methods of the four studies in this thesis according to the transgenic mouse lines 
used. 
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5 RESULTS AND DISCUSSION 
 
5.1 Changes in pharmacological sensitivity caused by the ?2I77 mutation 
 
As previously described, transgenic mice with the ?2I77 point mutation were phenotypically 
normal and showed no behavioral anomalies compared to wild-type (WT) littermate control 
mice  (Cope  et  al.,  2004).  The  GABAA receptor  levels  of  ?2I77  mice  were  similar  to  WT  
mice, as indicated by unaltered basal binding levels in [35S]TBPS autoradiography (I, Fig. 1). 
Thus the I77 point mutation in the ?2 subunit does not appear to alter synaptic clustering or 
the formation of functional GABAA receptors. However, as predicted on the basis of earlier 
work done on recombinant receptors (Stevenson et al., 1995; Thomet et al., 1999), the 
sensitivity of ?2I77 receptors to the non-benzodiazepine structured substances zolpidem (an 
?1-selective agonist) and DMCM (an inverse agonist) was radically reduced.  
 
5.1.1 Abolition of zolpidem and DMCM high-affinity effects  
 
The ?2I77 point mutation affects the benzodiazepine binding site in the interface between the 
? and ? subunits and prevents the conventional effects of zolpidem and DMCM (Buhr et al., 
1997). In ?2I77 mice, unlike in WT mice, zolpidem at 3-6 mg/kg doses produces no sedative 
effects (Cope et al., 2004). A high 30 mg/kg dose of zolpidem did not prevent electroshock-
induced increase in the expression of the immediate early gene c-Fos, a marker of neuronal 
activity, in the hippocampus of ?2I77 mice (II,  Fig.  4).  The  inactivity  of  zolpidem  at  the  
benzodiazepine binding site of the GABAA receptor of ?2I77 mice was also indicated in 
autoradiographic assays of ?2I77 mouse brains by the inability of zolpidem to displace 
[3H]Ro 15-4513, a benzodiazepine site ligand (II, Fig. 1), and the lack of positive modulating 
effects to the binding of [35S]TBPS, a convulsant site ligand suitable for the measurement of 
GABAA receptor  levels  (II, Fig. 2B). Due to the disruption of the benzodiazepine binding 
site, DMCM did not exert its characteristic inverse agonistic action in ?2I77 mice: it did not 
elicit convulsions even at very high (60 mg/kg) doses, nor did administration of DMCM 
cause increased expression of c-Fos in the hippocampus of ?2I77 mice (I, Fig. 4). DMCM up 
to 60 mg/kg did not increase locomotor activity in ?2I77 mice in a staircase chamber or in an 
open  field  test  (I, Table 2), while in WT mice, even at very low doses, DMCM is an 
anxiogenic and increases locomotion (Stephens et al., 1987; Savic et al., 2006). 
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5.1.2 Residual low affinity effects of zolpidem and DMCM 
 
The lack of effects mediated through the benzodiazepine binding site in ?2I77 mice allowed 
the manifestation of residual activity of zolpidem and DMCM. These residual effects are 
smaller in magnitude and do not appear in vivo in  WT  animals  as  they  are  masked  by  the  
robust benzodiazepine site effects.  
 
A high 40 mg/kg dose of zolpidem decreased locomotor activity in an open field test in ?2I77 
mice (II, Fig. 5A), and a 60 mg/kg dose impaired motor coordination in a rotarod test (II, 
Fig. 5B). The impairment could not be reversed by flumazenil pretreatment, strongly 
implying that this residual effect was not being mediated through zolpidem binding to the 
benzodiazepine binding site. Zolpidem had no effect on the so-called loreclezole site, a low 
affinity  positive  modulator  binding  site  dependent  on  the  type  of  the  ? subunit  and  
independent on the presence of a ?2 subunit (II, Fig. 3). Other possible sites for the residual 
zolpidem actions include neuronal Ca2+ channels  (Taft  and  DeLorenzo,  1984;  Takahashi  et  
al., 1999). The residual activity was displayed also in ex vivo conditions: a high 10 ?M 
concentration of zolpidem slightly displaced [3H]Ro 15-4513 benzodiazepine binding and 
modulated [35S]TBPS binding in a similar manner to GABAergic positive modulators (II, 
Fig. 1A,C; Fig. 2B).  
 
DMCM also had residual effects in ?2I77 mice, mediated through a binding site previously 
discovered in recombinant receptors (Stevenson et al., 1995; Thomet et al., 1999), which it 
shares with the antiepileptic loreclezole (Wingrove et al., 1994). DMCM positively 
modulated the GABAA receptor and decreased locomotor activity in the open field test (II, 
Fig. 6), likely via the induction of mild sedation. 20 mg/kg DMCM also produced an 
anxiolytic-like effect in ?2I77 mice (I,  Table  2),  as  reflected  by  an  increased  amount  of  
entries into and time spent in the open arms of an elevated plus maze. In the plus maze test, 
no decreased locomotion was observed, possibly due to inherent differences between the 
open field and elevated plus maze paradigms and also slight background strain effects 
between the different batches of ?2I77 mice used. DMCM modulated fear learning in ?2I77 
mice, surprisingly enhancing the ability of a foot shock to produce a freezing response (II, 
Fig. 7). Positive modulators of the GABAA receptor  are  typically  amnestic  (Makkar  et  al.,  
2010); the memory-enhancing effect of DMCM may have resulted from an altered emotional 
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state during the acquisition phase of the experiment, as mild anxiety (in contrast to panic) has 
been shown to promote learning (Sieve et al., 2001). 
 
5.2 Lack of synaptic inhibition in PC-??2 mice does not cause motor deficits 
 
PC-??2 mice were created by excising the ?2 subunit selectively from cerebellar Purkinje 
cells via Cre/loxP mediated recombination. The globally zolpidem and DMCM-insensitive 
?2I77 mouse line, with the ?2 subunits additionally flanked by loxP recombination sites, was 
crossed with the L7Cre line, in which Cre recombinase is expressed selectively in cerebellar 
Purkinje cells from postnatal day 6, guided by the L7 promoter (Barski et al., 2000). The 
rationale for this was twofold: firstly it was wished to investigate the effect of a long-term 
lack of inhibition to the Purkinje cells from molecular layer interneurons, and secondly it was 
planned to contrast this static lack of inhibition produced with transgenic means to cell-type 
specific rapid, reversible modulation of inhibition. Purkinje cells are inhibited mainly by 
stellate and basket cells, with little to no inhibition from recurrent axon collaterals of Purkinje 
cells themselves in the adult mouse (Wulff et al., 2009b). The resulting mice (PC-??2 mice) 
lacked the ?2 subunit in Purkinje cells and consequently had no synaptic inhibition in this 
neuronal type. As proof of this, a lack of mIPSCs in Purkinje cells was demonstrated by 
whole-cell recordings from PC-??2 mice (III, Fig. 4A).  
 
5.2.1 Phenotype of PC-??2 mice 
 
Despite the lack of inhibition to Purkinje cells, PC-??2 mice displayed no phenotypical 
abnormalities and, perhaps surprisingly, little or no motor impairment. Their working 
memory, spatial memory, basal anxiety level, nociception, startle reflex and pre-pulse 
inhibition of startle were found to be normal compared to that of control mice. They learned 
to perform the rotarod (III, Figure 5A) and walking beam (Figure 7) tasks with only slight, 
initial impairment. Although PC-??2 mice had no deficits in performing learned motor tasks, 
they have been found to have strong impairment in the consolidation of motor memories in 
paradigms measuring the optokinetic and vestibulo-ocular reflexes (Wulff et al., 2009b). The 
conclusion from experiments performed with PC-??2 mice is that synaptic inhibition of 
Purkinje cells is indispensable for certain types of cerebellar learning, but not for others. The 
type of feedforward inhibition ablated from the Purkinje cells of PC-??2 mice may play a 
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role in memory functions also in other brain areas, such as the amygdala and hippocampus 
(Wulff et al., 2009b). 
Walking beam
0 1 2 3 4 5 6 7 8 9
0
20
40
60
?2I77
PC-??2
training day
tim
e 
to
 c
ro
ss
 (s
)
 
Figure 7. Motor training of PC-??2 mice on the walking beam. Mice were trained during 9 days to 
walk on a 1 m-long, 0.8 cm-diameter beam to home cage and the latency (s) to reach the cage was 
recorded. Daily averages ± SEM are depicted. n(?2I77)=5, n(PC-??)=5.
 
5.3 Cell-specific modulation of motor coordination in PC-?2-swap mice 
 
In order to achieve selective control over cerebellar Purkinje cells in the intact animal, wild-
type ?2F77 subunits were restored to the cerebellum via triple crossing ?2I77lox mice, L7Cre 
mice and a mouse line in which eGFP-tagged ?2F77 subunits were expressed in Purkinje 
cells.  The  aim  was  to  have  uniquely  zolpidem-  and  DMCM-sensitive  cells  in  an  otherwise  
insensitive background, enabling the targeted modulation of this cell type by systemic 
pharmacological exposure. The resulting PC-?2-swap mice had GFP-immunoreactivity in 
their Purkinje cell somata and proximal dendrites, confirming the restoration of ?2F77 
subunits to the GABAA receptors  in  Purkinje  cells  (III, Fig. 3). Whereas the PC-??2 mice 
lacked mIPSCs in Purkinje cells, in PC-?2-swap mice the mIPSCs had returned to levels 
comparable with ?2I77 control mice (III, Fig. 4A). Zolpidem increased the amplitude and 
decay of mIPSCs in PC-?2-swap Purkinje cells, unlike in ?2I77 controls, implying that there 
had been restoration of fully functional ?2 subunits (III, Fig. 4B). In contrast to the unaltered 
basal motor behavior of PC-??2 mice, where the lack of inhibition to Purkinje cells is static, 
when PC-?2-swap mice were administered cumulative doses (3+3+3 mg/kg, rotarod) or a 
single 12 mg/kg dose (walking beam) of zolpidem, an impairment of motor performance was 
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Examination at the mRNA level revealed the absence of the ?2 signal in areas rich in Pv-
positive cells (reticular nucleus of thalamus, inferior colliculus and cerebellum), whereas 
areas in which Pv-cells are in a minority (hippocampus, neocortex) no change in overall ?2 
levels was detected (Wulff et al., 2009a). The gross anatomical CNS morphology of Pv-??2 
mice was unaltered. Pv-??2 mice, like their Purkinje-cell targeted counterparts, lacked 
synaptic inhibition in the selected cell type, the Pv-positive neurons. Wulff et al., (2009a) 
investigated miniature IPSCs in hippocampal parvalbumin-positive interneurons of Pv-??2 
mice and found them to be absent, confirming the ablation of the ?2 subunit, which targets 
the GABAA receptor to the synapse. They also investigated hippocampal oscillations, a 
network function essential to many types of information processing, conveyed by Pv-positive 
interneurons, and found them to be impaired. Although gamma oscillations were intact in Pv-
??2 mice, theta oscillations were disrupted as well as the phase coupling between theta and 
gamma oscillations (Wulff et al., 2009a). 
 
5.4.1 Phenotype of Pv-??2 mice 
 
Basic phenotyping was first performed on the Pv-??2 mice. The mice were noticeably 
smaller than ?2I77 control mice and did not gain weight over time as much as their controls. 
Their gait and posture were abnormally flat, although not sufficiently to impair basic 
locomotive behavior. Nevertheless they learned certain motor tasks, such as the rotarod and 
walking beam, incompletely and never reached the level of ?2I77 controls (IV, Fig. 7A,B). 
Further  testing  of  the  deficits  observed  in  the  behavioral  screen  (IV,  Table  1)  revealed  that  
Pv-??2 mice also had an increased startle reflex, decreased pre-pulse inhibition of startle (IV, 
Fig. 5), a decreased level of anxiety (IV, Fig. 4), decreased thermal nociceptive sensitivity 
(IV, Fig. 8), impaired spatial learning (IV, Fig. 6) and abnormal expression of tremor.  
 
5.4.2 Increased pharmacological sensitivity of Pv-??2 mice 
 
The motor pharmacological responses of Pv-??2 mice were altered as compared to ?2I77 
mice. Their sensitivity to the motor impairment caused by cumulative administration of 
flurazepam was increased (Figure 9). The increased sensitivity to flurazepam could be caused 
by the interaction of a heightened inhibitory load to the principal cells in a variety of brain 
areas resulting from increased activity of Pv-interneurons lacking synaptic inhibition, and the 
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inhibitory effect of flurazepam on the GABAA receptors of the principal cells themselves. As 
expected, on the rotarod the sensitivity of Pv-??2 mice to the inverse agonist DMCM was 
unaltered, but in tests measuring thermal nociception, 3 mg/kg DMCM produced an analgesic 
effect in Pv-??2 mice (IV, Fig. 8B). Administration of 20 mg/kg zolpidem to Pv-??2 mice 
resulted in motor impairment on the rotarod (IV, Fig. 7C). The reason for this unexpected 
sensitivity is unclear, but may be related to the residual sensitivity of the background ?2I77 
line to zolpidem (II), possibly caused by zolpidem inhibiting neuronal Ca2+ channels (Taft 
and DeLorenzo, 1984; Takahashi et al., 1999). The lack of impairment by residual effects of 
zolpidem in the control ?2I77 mice was likely due to the excessive facility of the 5?20 rpm 
rotarod task, which was the highest speed at which the Pv-??2 mice could reliably perform. 
However, the residual motor effect was seen in ?2I77 mice with a more difficult rotarod task 
at high zolpidem doses (II, Fig. 5B). 
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Figure 9. Motor pharmacological sensitivity of 
Pv-??2 mice to flurazepam. *, p<0.05, for the 
significance of the difference compared to 
saline or vehicle (one-way ANOVA and 
Dunnett’s post hoc test).  #, ##, ### p<0.05, 
p<0.01, p<0.001, respectively, for the 
difference between mouse lines, two-way 
ANOVA and Newman-Keuls post hoc test.
5.4.3 Increased GABA-insensitive binding in Pv-??2 mice 
 
 [35S]TBPS autoradiography was used to investigate the amount and composition of GABAA 
receptors in Pv-??2 mice. GABA reduces the binding of this convulsant site ligand to the 
receptor, and changes in the efficacy of GABA may indicate changes in receptor subunit 
composition. In Pv-??2 mice, the effect of 2 ?M GABA was increased in several midbrain 
areas, including the substantia nigra pars reticulata, periaqueductal gray area and raphe 
nucleus. Interestingly, largely in these same areas (though not completely overlapping), 
GABA-insensitive (GIS) binding was increased as compared to control ?2I77 mice (Figure 
10; IV, Fig. 3A, Supplementary Table 1). In GIS binding, high 1 mM concentrations of 
GABA are not able to completely displace [35S]TBPS from the receptor. This kind of binding 
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is attributed to binary GABAA receptors composed of ? and ? subunits, and is a hallmark of 
this mainly extrasynaptic receptor subtype (Sinkkonen et al., 2004). On the basis of these ex 
vivo findings, it is plausible that in Pv-??2 mice, in the absence of synaptic inhibition, an 
upregulation of binary extrasynaptic ?? receptors has taken place to compensate for the 
imbalance in excitation and inhibition in Pv-positive cells.  
 
 
 
Figure 10. Basal [35S]TBPS binding and the effect of 2 ?M and 1 mM GABA in ?2I77, Pv-??2 and Pv-
??2-partial rescue mice, aged 3-6 months (bregma level -2.60 mm). Ctx, cortex; CPu, caudate 
putamen; Hi, hippocampus; Th, thalamus; IC, inferior colliculus; Gr, cerebellar granule cell layer; Mol, 
molecular layer. 
 
5.5 Partially restored synaptic inhibition in Pv-??2-partial rescue mice 
 
In an attempt to replicate the cell-type selective modulation of activity achieved in PC-swap 
mice (IV), Pv-??2-partial rescue mice were produced. To simplify the otherwise extensive 
breeding scheme, which would have included the production and crossing of three separate 
mouse lines, two transgenes were co-integrated to produce the Pv-??2-partial rescue mice. 
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The mixing and co-injection into pro-nuclei of two bacterial artificial chromosome transgenes 
will often result in their integration into the same genomic position. This strategy ultimately 
resulted in mice with an ablation of the ?2 subunit in Pv-positive cells and a restoration of the 
?2F77 subunit at detectable levels to the reticular thalamic nucleus and cells in the cerebellar 
molecular layer. This unfortunately incomplete restoration nevertheless provided an 
opportunity to compare Pv-??2 and Pv-??2-partial rescue mice and to elucidate the effects 
on the various behavioral modalities of the restored synaptic inhibition in these restricted 
areas.  
 
5.5.1 Restoration of the ?2F77 subunit to reticular thalamic nucleus and molecular 
layer of cerebellum 
 
In the ?2I77 background line, the mutated benzodiazepine binding site of the GABAA 
receptor only weakly binds several ligands, including [3H]Ro 15-4513, a partial inverse 
agonist used for the visualizing of the benzodiazepine binding site (Makela et al., 1997). In 
Pv-??2-partial rescue mice, the restoration of the ?2F77 subunit could clearly be seen as the 
increased signal in the reticular nucleus of thalamus and the cerebellar molecular layer (IV, 
Fig. 2A). The binding levels in these areas were 55% and 16%, respectively, from those of 
wild-type homozygous ?2F77 mice. The restoration of ?2F77 subunit protein to Pv-cells in 
other brain areas cannot be excluded, since despite their importance to network functions, Pv-
cells are a minor neuronal type in many areas (e.g. neocortex, hippocampus), and the 
autoradiographic and in situ hybridization methods used here are not suitable for the 
detection of such low-level signals.  
 
5.5.2 Improvement of motor function and spatial learning 
 
The clearest difference between Pv-??2 and Pv-??2-partial rescue mice was the reversal of 
motor deficits. While Pv-??2 had a noticeably abnormal gait (belly and tail held low to the 
ground, flattened body posture) the movements of Pv-??2-partial rescue mice appeared 
normal, although they were slightly hyperactive, as seen in their increased locomotion in 
several behavioral experiments. Pv-??2-partial rescue mice performed better on the rotarod 
and learned to stay on a rod accelerating from 5 to 30 rpm in contrast to the lower maximal 
speed of 5 to 20 rpm used with Pv-??2 mice. The cognitive abilities of Pv-??2-partial rescue 
mice were improved in the Morris water maze paradigm as compared to Pv-??2 mice; this 
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being indicated by their lower escape latencies during training, and the increased number of 
visits  to  the  former  platform position  in  the  probe  trial  (IV,  Fig.  6).  However,  some of  the  
other phenotypic and behavioral abnormalities (lower body weight, tremor, increased startle 
reflex, decreased pre-pulse inhibition of startle, decreased anxiety level and decreased 
thermal nociception) apparent in Pv-??2 mice were also present in Pv-??2-partial rescue 
mice. The ablation of the ?2 subunit from Pv-cells produced so many and such wide-ranging 
alterations  that  it  is  unrealistic  to  attempt  to  pinpoint  them  to  any  single  brain  structure  or  
area, and likewise the restoration of the ?2F77 subunit to only a few, restricted areas could 
not reverse the majority of the deficits produced by the lack of the ?2 subunit in Pv-cells. 
 
5.5.3 Altered pharmacological responses of Pv-??2-partial rescue mice 
 
Surprisingly, Pv-??2-partial rescue mice did not show an increased sensitivity to zolpidem 
compared to ?2I77 control mice, and still did not exhibit the increased sensitivity to zolpidem 
manifested in Pv-??2 mice. Although this is likely to be a consequence of the normalization 
of synaptic inhibition in Pv-cells, the exact mechanism is unclear. It is possible that the 
impaired motor performance of Pv-??2 mice together with the residual sensitivity of the 
background ?2I77 line produced an exceptional sensitivity to zolpidem in Pv-??2 mice. The 
situation may have been reversed in Pv-??2-partial rescue mice, in which the baseline motor 
performance was improved and so may have rendered them less prone to disturbance by the 
slight residual effects of zolpidem. The motor sensitivity of Pv-??2-partial rescue mice to 
flurazepam was also normalized as compared to Pv-??2 mice. Presumably the abnormally 
strong inhibitory drive from Pv-cells toward principal cells was reduced by the restored 
synaptic inhibition of Pv-cells to the level of ?2I77 control mice and thus the flurazepam 
administration did not cause a stronger impairment in motor function than that detected in the 
control mice (Figure 11). Finally, the administration of a single, low dose of DMCM to Pv-
??2-partial rescue mice resulted in motor impairment on the rotarod, an impairment which 
could be partially reversed by flumazenil pretreatment (III,  Fig.  7C).  This  can  be  taken  as  
another confirmation of the restoration of the ?2F77 subunit. When Pv-cells are disinhibited 
by  the  inverse  agonist  action  of  DMCM  in  GABAA receptors, their inhibitory load toward 
principal cells is increased, the situation resembling that of the baseline motor performance of 
Pv-??2 mice, where static loss of synaptic inhibition in Pv-cells results in a significant 
impairment. 
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6 GENERAL DISCUSSION 
 
Cell-type specific modulation of selected components of neural circuits has been a long-time 
goal in the quest toward understanding the meaning of different neuronal types to the whole 
of the CNS. By isolating a single part of a circuit and modulating its function independently 
of the other components, one can gather essential information on its role. The studies in this 
thesis  have  aimed  at  developing  a  rapid,  reversible  method  of  regulating  the  activity  of  
specific cell types in vivo in awake, behaving animals, and subsequently attributing the 
significance of these cell types to various behavioral modalities through the use of 
pharmacological tools. A transgenic approach was used to engineer a cell-type selective 
sensitivity to both an inhibitory and an excitatory systemically administered compound in a 
brain which should be otherwise insensitive to these pharmacological agents. Purkinje cells 
were chosen as a target for the validation of the method due to ease of access of their 
reasonably well-defined cerebellar circuitry. After confirming the feasibility of the method, it 
was further used to investigate the importance of Pv-positive cells in mouse emotional, 
cognitive and motor behavior.  
 
6.1 Earlier models of cell-type specific modulation 
 
Previous work on selective modulation of neuronal activity has utilized a variety of different 
methods. One fundamental, widely used strategy of modulating neuronal function has been 
the genetic ablation of target proteins, e.g. neurotransmitter receptors, uptake proteins or 
synthesizing enzymes (Günther et al., 1995, Stork et al., 2000, Salichon et al., 2001). 
However, as few such targets are restricted to one cell type or brain area only, additional 
techniques for the restriction of the desired effect to the cell type of interest are required. The 
next generation of genetic manipulations may be driven by cell-type specific promoters to 
affect only a subset of neurons. One limitation of this approach is the number of suitable 
promoters available; although promoters for cerebellar Purkinje cells (Barski et al., 2000), 
parvalbumin-positive cells (Fuchs et al., 2007), hippocampal CA3 neurons (Nakazawa et al., 
2002) and olfactory neurons (Isles et al., 2001) have been described. Through the use of these 
promoters, a number of alterations in the properties of the cells in question can be achieved, 
from ectopic expression of protein (Wisden et al., 2002) to knock-out of subunits of 
inhibitory or excitatory receptors (Homanics et al., 1997; Lyon et al., 2011). Several ways of 
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excising and introducing proteins are known. In the present studies the Cre/loxP technique 
was used, where the Cre recombinase enzyme removes a target flanked by loxP 
recombination sites (Lakso et al., 1992, Meyer et al., 2002). The Cre recombinase was driven 
by cell-type specific promoters in the L7Cre mouse line (Purkinje cells (Barski et al., 2000)) 
and the PvCre mouse line (Pv-positive neurons (Fuchs et al., 2007)) which were then crossed 
with the background GABAA??2I77 line to remove the ?2 subunit in the target cell types. In 
this way static knockout mice were generated, where the absence of synaptic inhibition 
begins at the time of L7- (after postnatal day 6 (Barski et al., 2000)) and Pv- (after postnatal 
day 7 (Fuchs et al., 2007)) promoter expression. Ablation of a protein is not the only way to 
remove its influence. In other studies, the tetracycline (Gossen and Bujard, 1992) and 
mifepristone-inducible (Pierson et al., 2000) techniques have been used to silence the activity 
of target genes by activation or inactivation of transcription. Area-specific silencing of 
activity can be achieved through stereotaxic injections of inhibitory substances (Jasnow and 
Huhman, 2001). 
 
Cre recombinase and similar methods of excision of genetic material can also be guided to 
selected brain areas, instead of specific cell types, via injection of viral vectors to the brain. 
Important considerations when using viral vectors are the selectivity of the virus to neuronal 
cells, rate of infection, efficacy of transfection, expression level of the delivered transgene 
following transfection, and absence of viral spreading to neighboring areas. The viral delivery 
tactic could also be combined with cell-type specific promoters to achieve restriction of the 
transgene  both  spatially  and  to  only  a  subset  of  neurons  in  the  target  area  (Kravitz  et  al.,  
2010). Covering of large areas with viral delivery is challenging due to the limited area of 
diffusion of the vector. Targeting of cell types to a wide, but sparse distribution is not feasible 
with this method (Boyden et al., 2005; Gradinaru et al., 2010). It has been suggested that in 
animal species not amenable to standard transgenic techniques, viral delivery of transgenes to 
modulate activity in specific areas or cell types could prove very useful (Tan et al., 2006). 
 
Other strategies of silencing the activity of cells range from the expression of tonically active, 
inward-rectifying potassium channels (Nadeau et al., 2000) to invermectin-activated Cl-
channels (Slimko et al., 2002) and membrane-tethered toxins, which inactivate target 
channels in the neurons to which they become attached to (Ibanez-Tallon et al., 2004). Such 
permanent modulations of cell excitability may render the neurons vulnerable to apoptosis 
(Nadeau et al., 2000) and thus may not be suitable for in vivo experiments. In the study of 
74 
 
(Coward et al., 1998) a system was developed where genetically engineered G-protein 
coupled receptors were activated selectively by synthetic ligands. 
 
All of these approaches, particularly those involving deletions of essential proteins, that rely 
on genetic modifications during the embryonic stages, run the risk of unexpected 
compensatory changes, as was also the case in our studies of the Pv-??2 and Pv-??2-partial 
rescue mice. However, the background ?2I77 mutation used in our studies was 
phenotypically inert. In contrast to static genetic alterations, a rapid time scale and 
reversibility of modulation are key factors in the success of the cell-type specific modulation 
scheme, if the method is to stand the ultimate test of real-time regulation of neuronal activity 
at the whole animal level, in awake, behaving animals. In the work of Karpova et al., (2005) a 
fairly rapid induction of modulation (20-30 min) was achieved with molecules for inhibition 
of synaptic transmission (MIST), the transgenically introduced dimerization-caused 
inactivation of synaptic proteins, but termination of the effects still took over 24 hours. In 
addition, in this study no electrophysiological proof of actual synaptic events was obtained 
from transgenic animals, although the induction of motor impairment during training and 
performance of the rotarod task was observed (Karpova et al., 2005). Still more rapid 
timescales (several minutes) were achieved in another study with the introduction by viral 
vector of the Drosophila-derived allatostatin receptor, which couples to the mammalian 
inward rectifying K+ GIRK channel (Lechner et al., 2002) and subsequent application of 
allatostatin  topically  to  brain  surfaces  (Tan  et  al.,  2006).  However,  as  the  diffusion  of  
allatostatin in the cerebral tissue was modest, areas distant from the cerebral surface and the 
ventricles would be unreachable with this method. Systemic administration would not be 
feasible, as allatostatin does not cross the blood-brain barrier (Tan et al., 2006). One 
advantage of the allatostatic-receptor system, as well as the MIST system described by 
Karpova et al., (2005) is its good specificity, since allatostatin and MIST do not affect cells 
without the introduced receptor or dimerization molecule, respectively. 
 
An interesting new branch of research, optogenetics, is a potentially groundbreaking way to 
modulate  target  neurons  with  pinpoint  accuracy.  This  relies  on  the  expression  of  light-
sensitive channelrhodopsin-2, a Chlamydomonas alga-derived cation channel activated by 
certain wavelengths of light (Boyden et al., 2005). When the protein is introduced either 
through viral delivery or with transgenic methods into neurons, which are subsequently 
illuminated, modulation of the activity is achieved within seconds (Boyden et al., 2005, 
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Gradinaru et al., 2010). Lin et al., (2011) used optogenetics to reversibly modulate 
hypothalamic areas to induce and abolish aggressive behavior, and Tye et al., (2011) 
provided proof for a centromedial amygdaloid circuit in the regulation of anxiety. The light-
activated channelrhodopsin-2 is an elegant way of regulating the actions of neurons, with 
ultra-fast induction and termination of effect, but it does require both a reliable way, either 
genetic or a viral vector, to deliver the transgene needed for channel expression, which is as 
labor-intensive as in the older approaches, and also the invasive implantation of the 
fiberoptics to provide the light source. Nevertheless, optogenetics does hold great future 
promise in the field of cell-type specific modulation. 
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Method  Specificity Time scale Reversibility Reference 
Promoter-driven good permanent from     - Nakazawa et al., 2002 
deletion of subunit  embryonic stage     Korotkova et al., 2010
     
Receptors activated poor na         + Coward et al., 1998 
solely by synthetic  
ligands (RASSL) 
 
Membrane-tethered poor permanent          - Ibanez-Tallon et al., 2004 
toxins 
 
Overexpression of  poor permanent          - Nadeau et al., 2000 
tonically active K+      
channels     
 
Cl- channels activated good several hours         + Slimko et al., 2002 
by ivermectin 
 
Infusion of muscimol to poor minutes to hours    + Jasnow&Huhman, 2001 
central amygdala 
 
Promoter-driven  good  permanent          - Isles et al., 2001 
toxic ablation of  
olfactory neurons 
 
Molecules for inhibition good I:  20-30 min         + Karpova et al., 2010 
of synaptic transmission  T: >24 h 
 (MIST)   
 
Ectopic allatostatin- good minutes          +   Lechner et al., 2002  
receptor expression    Tan et al., 2006
  
Optogenetics  good seconds          + Lin et al., 2011  
     Tye et al., 2011 
 
Selective zolpidem- and  good seconds          + III, IV 
DMCM modulation of  
Pv- and Purkinje cells 
 
Table 4. Methods of cell type- or area specific modulation of neuronal activity. 
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6.2 The zolpidem method 
 
The present approach relied on a strategy with no invasive steps necessary at any phase, by 
placing the appropriate genetic manipulations in place through crossbreeding of the suitable 
mouse lines. A similar strategy of cell-type specific knockout of a receptor subunit was 
recently used by Korotkova et al., (2010); they ablated the mandatory NR1-subunit of the 
glutamatergic NMDA receptor in Pv-cells, which resulted in cognitive deficits in the mice 
due to disturbances in hippocampal oscillatory function. For the relatively straightforward 
goal of simply knocking out the GABAA receptor ?2 subunit in selected cells, the genetic 
manipulations could have been performed with two transgenic mouse lines (the floxed line 
and the Cre carrier line), but to reach the ultimate target, rapid and reversible modulation of 
activity, a different background line was needed. From previous work on recombinant 
receptors, it was known that the ?2 subunit could be altered in such a way that the sensitivity 
to several benzodiazepine binding site substances, e.g. the sedative-hypnotic zolpidem and 
the inverse agonist convulsant DMCM would be abolished (Buhr et al., 1997; Wingrove et 
al., 1997). The ?2I77 point mutation was introduced to a transgenic mouse line without 
affecting the sensitivity to other GABAergic substances or producing phenotypic changes 
(Cope et al., 2004). This mouse line was used for the ablation of the ?2 subunit in the target 
neurons i.e. the cerebellar Purkinje cells and parvalbumin-positive neurons. Static knockouts 
of the ?2 subunit, used for comparison with the rapid modulation model, were achieved, 
leading to loss of synaptic inhibition in Purkinje cells and Pv-cells. The final step in the cell-
type specific modulation was to substitute the wild-type ?2F77 subunit for the ?2I77 subunit 
in the target cells. This was accomplished as planned in the PC-?2-swap mouse line, but only 
incompletely  in  the  Pv-??2-partial  rescue  line.  However,  the  overall  aim  of  modulation  of  
specific neurons through systemic administration of pharmacological substances was 
achieved in both PC-?2-swap and (most likely) in the Pv-??2-partial rescue mice. 
 
The advantages of the present method, as established in the study of the PC-?2-swap mice, 
are 1) the accurate targeting of the modulation to cells expressing the L7 promoter, the 
Purkinje cells; the more specific the promoter, the better the precision. When the changes 
required for the selective sensitivity to pharmacological modulation are achieved through 
transgenic methods, one does not need to attempt invasive procedures such as stereotaxic 
injection of viral vectors to small, difficult-to-reach brain areas. 2) Systemic administration of 
the modulating substance. Again, neither invasive procedures, nor permanent implantation of 
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fiberoptics or intracerebral cannulas are needed, reducing the operative load on the animal 
and simplifying the performance of possible behavioral experiments. 3) Rapid time scale of 
induction and termination of effect. The kinetics of zolpidem in particular are fast, its effect 
appearing within minutes of intraperitoneal injection (II, III, IV) and reaching a maximum in 
10 minutes, with a half-life of 20 minutes (Benavides et al., 1988). The effects of both 
zopidem and DMCM can furthermore be reversed with the pharmacological antagonist, 
flumazenil, enabling the interruption of the effect at a selected time point, if that were 
deemed necessary in the behavioral paradigm. 
 
Despite the success with the PC-?2-swap mice, the mixed results obtained with the Pv-??2-
partial rescue mice reveal the need for further refinements of this method. The crossbreeding 
of three mouse lines is labor-and time-intensive. The success of the breeding scheme cannot 
be easily evaluated at intermediate stages, but can only be ascertained at the end. Short cuts 
by co-integration of more than one construct may result in an unreliable pattern of expression 
of the target protein. A possible future direction for the present studies could be the viral 
delivery of the Cre recombinase driven by a cell-type specific promoter in the ?2I77 mouse 
line to attain selective modulation in discrete brain areas. Despite the inherent challenges in 
the use of viral vectors, this direction of research holds great interest in investigating area-
specific functions. In particular, the widespread deficits observed in Pv-??2 mice merit 
further  research  to  pinpoint  the  alterations  of  behavior  to  disruption  of  the  function  of  Pv-
cells to discrete areas, such as the amygdala, the basal ganglia or the spinal cord. The original 
aim of bidirectional modulation of activity was not fully achieved in PC-?2-swap or Pv-??2-
partial rescue mice, but could perhaps be fulfilled better in another neuronal type, where both 
inhibition and excitation of the neuron had a robust effect on the network. 
 
6.3 Benefits of the ?2I77 as a background line 
 
In addition to the ?2I77 line being a necessary background line and an essential intermediary 
toward  cell-type  specific  modulation,  it  was  possible  to  reveal  residual  effects  of  zolpidem 
and DMCM, main pharmacological tools in these studies, in ?2I77 mice. Since in the studies 
of cell-type specific modulation, high doses of zolpidem were used, it was important to first 
quantify their effects in the background line, in order to be sure of the correct interpretation 
of the results in the Purkinje- and Pv mouse lines. The effects of high-dose (20-40 mg/kg) 
DMCM in ?2I77 mice were positively modulating, in contrast to the strong inverse agonism 
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in wild-type mice. DMCM is known to affect a low-affinity binding site of the GABAA 
receptor which is common with the anticonvulsant loreclezole (Wafford et al., 1994, 
Stevenson et al., 1995), and it is most likely that this site was responsible for the mild 
agonistic effects observed (anxiolysis, sedation, modulation of fear learning, enhancement of 
GABA effects in [35S]TBPS tissue autoradiography). Zolpidem also manifested slight 
residual effects, but not through this same site. The site of these zolpidem residual properties 
remains to be further investigated, but may be neuronal Ca2+ channels, where zolpidem was 
previously shown to have an effect (Taft and DeLorenzo, 1984; Takahashi et al., 1999). For 
the first time it was possible to demonstrate the residual sedative and motor-impairing effects 
of high-dose zolpidem in vivo in the ?2I77 mice, which are insensitive to the conventional 
benzodiazepine site effects of this substance. There might be some clinical significance to the 
residual effects of zolpidem, as Ca2+ channel blockers are widely used for cardiovascular 
indications, and interactions with high doses zolpidem could conceivably arise. The biphasic 
effect of DMCM is shared by other benzodiazepine site ligands, such as diazepam (Walters et 
al., 2000), and it would be possible to explore the structural determinants of the dual affinity 
to the benzodiazepine site and the loreclezole site to avoid unintentional side effects as well 
as for exploiting the duality in future research or clinical settings. The ?2I77 mouse line has 
also proved to be useful in dissecting the molecular-level activity of ethanol on the GABAA 
receptor; antagonism of ethanol effects by the inverse agonist Ro 15-4513 was absent in 
?2I77 mice, implying that the antagonism may be mediated through the benzodiazepine 
binding site (Linden et al., 2011). 
 
6.4 Static versus dynamic modulation of Purkinje cells 
 
The results obtained from the study of the Purkinje cell transgenic mouse lines revealed a 
contrast between static and dynamic modulation of cerebellar motor performance. Little to no 
motor deficits were observed in PC-??2 mice. Although the motor learning process and the 
performance of a complex motor task i.e. the rotarod, were intact in PC-??2 mice, it is 
important to note that there was impairment of the consolidation of memories in another type 
of motor experiment investigating the optokinetic and vestibulo-ocular reflexes (Wulff et al., 
2009b). The possibility of compensatory changes in the synaptic composition of GABAA 
receptors in PC-??2 mice, acting toward a re-establishment of the balance between inhibition 
and excitation, cannot be excluded. In that respect, it has been postulated that there may be 
decreased glutamatergic currents in the Purkinje cells of PC-??2 mice (Wulff et al., 2009b).  
80 
 
 
Opposite to the lack of deficits in rotarod performance in PC-??2 mice, in PC-?2-swap mice 
cumulative administration of zolpidem resulted in motor impairment on the rotarod, 
presumably due to acute inhibition of Purkinje cell activity and the consequent disinhibition 
of deep cerebellar nuclei. Similar results have been presented by (Karpova et al., 2005), 
through the inhibition of synaptic transmission in Purkinje cells, albeit with slower kinetics of 
onset and termination. The administration of the inverse agonist DMCM, possibly 
disinhibiting the Purkinje cells, did not alter the motor behavior observed in the PC-?2-swap 
mice. This resembles the situation in the PC-??2 mice, where there is a static loss of synaptic 
inhibition and presumably consequent disinhibition of Purkinje cells. On the basis of this 
comparison between static and dynamic modulation of Purkinje cell activity in vivo, it 
appears that the output of the Purkinje cells to the deep cerebellar nuclei is more prone to 
interference with increased than decreased inhibition of Purkinje cell activity.  
 
6.5 Lack of synaptic inhibition in Pv-cells causes wide-ranging behavioral alterations 
partially reversed by the restoration of the wild-type ?2F77 subunit 
 
The major alterations in behavior and GABAA receptor composition we observed in Pv-??2 
mice  confirm  the  essential  role  of  Pv-positive  cells  in  a  wide  variety  of  brain  areas  and  
behavioral modalities. A lack of synaptic inhibition in Pv-cells of Pv-??2 mice was 
established earlier by (Wulff et al., 2009a). The present experiments with [35S]TBPS binding 
point to a compensatorially increased amount of extrasynaptic receptors of the low-
conductance binary ?? subtype, the hallmark of which is increased GABA-insensitive 
binding, observed particularly in midbrain areas (substantia nigra pars reticulata, 
periaqueductal gray area and raphe nucleus) of Pv-??2 mice. Based on these behavioral 
findings (motor and cognitive impairment, increased startle reflex, decreased pre-pulse 
inhibition of startle, a decreased level of anxiety, decreased thermal nociception, and altered 
GABAergic pharmacological sensitivity), the putative increase in extrasynaptic transmission 
was not able to compensate for the lack of synaptic inhibition in Pv-??2 mice. The loss of 
afferent inhibition to Pv-cells likely disinhibits their activity and consequently increases the 
inhibitory load toward principal cells.  In the diverse areas where Pv-cells form an essential  
part of networks for cognitive processing, this altered level of inhibition is would be 
predicted to cause severe disturbances. Indeed, the coupling of gamma and theta oscillations 
is known to be disrupted in the hippocampus of Pv-??2 mice (Wulff et al., 2009a), which can 
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be a major factor in the cognitive deficits observed in the water maze performance of Pv-??2 
mice. Interestingly, Korotkova et al., (2010) found that ablation of the glutamatergic NMDA 
subunit selectively from Pv-cells impaired some forms of memory, in addition to changes in 
oscillatory activity. Pv-??2 mice also had a decreased level of theta oscillations (Wulff et al., 
2009a), which may be connected to their decreased level of anxiety. In a mouse model with 
an  ablation  of  the  5-HT1A receptor, both increased anxiety and increased theta oscillations 
were observed (Gordon et al., 2005). Benzodiazepines tend to decrease theta oscillations 
(Zhu and McNaughton, 1995). Both of these observations together with the present results of 
decreased anxiety and decreased theta oscillations in Pv-??2 mice provide support for a role 
for hippocampal Pv-neurons in the regulation of anxiety. Apparently the network function of 
Pv-cells is delicately balanced and sensitive to disturbances in both the inhibitory and the 
excitatory directions. 
 
A partial restoration of synaptic inhibition in Pv-??2-partial rescue mice was achieved, 
reflected in the reversal of motor deficits on the rotarod and walking beam tasks, as well as 
the improved spatial learning in the water maze. The restoration of wild-type ?2F77 subunits 
was confirmed in the reticular nucleus of thalamus and the cerebellar molecular layer by 
[3H]Ro 15-4513 binding, a benzodiazepine binding site ligand suitable for the detection of the 
?2 subunit. The restoration in other brain areas, e.g. neocortex and hippocampus, cannot be 
excluded, but the autoradiographic method is not suited for detecting the low, sparsely 
distributed signals emitted by Pv-cells, in regions where they are in a minority. Nonetheless, 
[35S]TBPS autoradiography experiments revealed widespread changes in GABAA receptor 
composition in Pv-??2-partial rescue brains fully comparable to those in Pv-??2 brains, 
implying that a major part of the cellular-level deficits still remain. At the behavioral level 
this is manifested by the unaltered phenotype of Pv-??2-partial rescue mice compared to Pv-
??2 mice, except for motor and cognitive behavior. This is due to the limited success of the 
present method to restore the ?2F77 subunit to Pv-cells only in the reticular thalamus and the 
cerebellum, whereas in other areas there is a loss of ?2 subunit and a consequent lack of 
synaptic inhibition, similar to that encountered in Pv-??2 mice. To accurately dissect which 
behavioral alterations of Pv-??2 and Pv-??2-partial rescue mice were attributable to which 
brain areas where autoradiographic changes were detected was not within the scope of these 
studies. It would be interesting to target selected areas with the zolpidem method, possibly 
via viral delivery of Cre recombinase and insertion of the ?2F77 subunit, to achieve in-depth 
information on the area-specific functions of Pv-cells. 
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In summary, it can be stated that the present method of cell-type specific, rapid and reversible 
modulation of neuronal activity is a feasible way of dissecting the role of single neuron types 
(Pv-positive cells or cerebellar Purkinje cells) within a network. Provided that suitable 
promoters are available, the method could be utilized in investigating further GABAA 
receptor ?2 subunit expressing cell types. The systemic administration and fast time course of 
zolpidem and DMCM allow for performance of a variety of different behavioral paradigms. 
However, when constructing the transgenic mouse lines, due care must be taken to ascertain 
the desired expression pattern of the ?2F77 subunit in order to avoid incomplete expression 
and mosaicism of the receptor protein in the target cells. 
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7 CONCLUSIONS 
 
1. The inverse agonist DMCM and the sedative-hypnotic zolpidem both have residual activity 
mediated through non-benzodiazepine binding sites at high doses in the GABAA receptor, as 
revealed in the ?2 subunit I77 point mutant mice. The inability of the benzodiazepine 
antagonist flumazenil to reverse the effects of zolpidem supports the involvement of a non-
benzodiazepine  site  of  action.  Both  DMCM  and  zolpidem  have  effects  pointing  toward  
positive modulation at the GABAA receptor. Both substances also act as positive modulators 
in the [35S]TBPS autoradiographic assay at high concentrations.   
 
2. A lack of synaptic inhibition was confirmed in the Purkinje cells of PC-??2 mice, but this 
evoked little or no impairment in motor learning and performance on the rotarod test. Either 
the lack of synaptic inhibition is being compensated for by changes in receptor subunit 
composition, or the output of the cerebellar cortex to deep cerebellar nuclei is not disrupted 
by the elevated level of inhibition from Purkinje cells. 
 
3. Fast, reversible inhibition of Purkinje cells was achieved by systemic, cumulative 
administration of zolpidem in PC-?2-swap mice. This caused a transient impairment in their 
motor performance on the rotarod and walking beam. It is postulated that compared to the 
static loss of inhibition in PC-??2 mice, the output of the cerebellar cortex to deep cerebellar 
nuclei had been disrupted by the putative sudden decrease of inhibition from Purkinje cells 
caused by the administration of zolpidem. 
 
4. The lack of synaptic inhibition in Pv-cells caused wide-ranging behavioral alterations in 
Pv-??2 mice. The increased GABA-insensitive binding, particularly in midbrain areas, 
implies that changes in GABAA receptor subunit composition had occurred, possibly an 
increased amount of extrasynaptic ?? subtype receptors. The observed behavioral alterations 
particularly in cognition and emotion support previous studies on the role of Pv-cells as being 
essential to network oscillations and coordination of principal cell firing e.g. in neocortex and 
hippocampus. 
 
5. In Pv-??2-partial rescue mice the wild-type ?2F77 subunit was restored to the reticular 
nucleus of thalamus and the cerebellar molecular layer, which alleviated the cognitive and 
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motor impairments detected in Pv-??2 mice, highlighting the important role of these 
structures in cognition and motor control. Systemic administration of DMCM resulted in fast, 
reversible motor impairment in Pv-??2-partial rescue mice, mediated through the 
benzodiazepine binding site.  
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